View Filing Data

Print Document View Excel Document

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2014	Nov. 06, 2014
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Trading Symbol	MPW
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC.
Entity Central Index Key	0001287865
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		172,454,688
MPT Operating Partnership, L.P. [Member]
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Entity Registrant Name	MPT Operating Partnership, L.P.
Entity Central Index Key	0001524607
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Real estate assets
Land, buildings and improvements, and intangible lease assets	$ 2,061,183	$ 1,865,455
Mortgage loans	385,093	388,756
Net investment in direct financing leases	436,386	431,024
Gross investment in real estate assets	2,882,662	2,685,235
Accumulated depreciation and amortization	(191,282)	(159,776)
Net investment in real estate assets	2,691,380	2,525,459
Cash and cash equivalents	132,812	45,979
Interest and rent receivables	50,240	58,565
Straight-line rent receivables	56,403	45,829
Other loans	147,418	160,990
Other assets	90,887	67,873
Total Assets	3,169,140	2,904,695
Liabilities
Debt, net	1,618,981	1,421,681
Accounts payable and accrued expenses	85,426	94,290
Deferred revenue	30,830	24,114
Lease deposits and other obligations to tenants	26,797	20,402
Total liabilities	1,762,034	1,560,487
Equity / Capital
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding	0	0
Common stock, $0.001 par value. Authorized 250,000 shares; issued and outstanding - 171,626 shares at September 30, 2014 and 161,310 shares at December 31, 2013	172	161
Limited Partners:
Additional paid in capital	1,752,885	1,618,054
Distributions in excess of net income	(337,817)	(264,804)
Accumulated other comprehensive loss	(7,872)	(8,941)
Treasury shares, at cost	(262)	(262)
Total Equity / Capital	1,407,106	1,344,208
Total Liabilities and Equity / Capital	3,169,140	2,904,695
MPT Operating Partnership, L.P. [Member]
Real estate assets
Land, buildings and improvements, and intangible lease assets	2,061,183	1,865,455
Mortgage loans	385,093	388,756
Net investment in direct financing leases	436,386	431,024
Gross investment in real estate assets	2,882,662	2,685,235
Accumulated depreciation and amortization	(191,282)	(159,776)
Net investment in real estate assets	2,691,380	2,525,459
Cash and cash equivalents	132,812	45,979
Interest and rent receivables	50,240	58,565
Straight-line rent receivables	56,403	45,829
Other loans	147,418	160,990
Other assets	90,887	67,873
Total Assets	3,169,140	2,904,695
Liabilities
Debt, net	1,618,981	1,421,681
Accounts payable and accrued expenses	49,197	58,538
Deferred revenue	30,830	24,114
Lease deposits and other obligations to tenants	26,797	20,402
Payable due to Medical Properties Trust, Inc.	35,839	35,362
Total liabilities	1,761,644	1,560,097
Limited Partners:
Accumulated other comprehensive loss	(7,872)	(8,941)
Total Equity / Capital	1,407,496	1,344,598
Total Liabilities and Equity / Capital	3,169,140	2,904,695
MPT Operating Partnership, L.P. [Member] \| Common Units [Member]
Limited Partners:
Limited Partners Capital	1,401,204	1,339,998
MPT Operating Partnership, L.P. [Member] \| General Partner [Member]
Equity / Capital
General Partner - issued and outstanding - 1,711 units at September 30, 2014 and 1,608 units at December 31, 2013	14,164	13,541
MPT Operating Partnership, L.P. [Member] \| LTIP Units [Member]
Limited Partners:
Limited Partners Capital	$ 0	$ 0

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2014	Dec. 31, 2013
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	171,626,000	161,310,000
Common stock, shares outstanding	171,626,000	161,310,000
General Partner [Member] \| MPT Operating Partnership, L.P. [Member]
General partner, units issued	1,711,000	1,608,000
General partner, units outstanding	1,711,000	1,608,000
LTIP Units [Member] \| MPT Operating Partnership, L.P. [Member]
LTIP Units, shares issued	363,000	292,000
LTIP Units, shares outstanding	363,000	292,000
Common Units [Member] \| MPT Operating Partnership, L.P. [Member]
Limited Partners, units issued	169,915,000	159,702,000
Limited Partners, units outstanding	169,915,000	159,702,000

Condensed Consolidated Statements of Income (Unaudited) shares in Thousands, $ in Thousands, £ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2014 USD ($) $ / shares shares	Sep. 30, 2013 USD ($) $ / shares shares	Sep. 30, 2014 USD ($) $ / shares shares	Sep. 30, 2013 USD ($) $ / shares shares
Revenues
Rent billed	$ 48,063	$ 31,544	$ 136,952	$ 94,072
Straight-line rent	5,282	2,884	10,648	8,352
Income from direct financing leases	12,308	11,298	36,787	29,284
Interest and fee income	15,124	14,380	46,039	43,136
Total revenues	80,777	60,106	230,426	174,844
Expenses
Real estate depreciation and amortization	13,354	8,714	39,485	25,827
Impairment charges			50,128
Property-related	700	458	1,401	1,520
General and administrative	8,672	6,285	25,836	21,162
Acquisition expenses	4,886	4,179	7,933	6,457
Total operating expenses	27,612	19,636	124,783	54,966
Operating income	53,165	40,470	105,643	119,878
Other income (expense)
Interest and other income (expense)	75	3	44	(245)
Earnings from equity and other interests	1,153	843	2,059	2,511
Interest income (expense)	(25,481)	(15,830)	(71,455)	(45,896)
Debt refinancing costs			(290)
Income tax benefit (expense)	(249)	(94)	(232)	(261)
Net other expense	(24,502)	(15,078)	(69,874)	(43,891)
Income from continuing operations	28,663	25,392	35,769	75,987
Income (loss) from discontinued operations		311	(2)	3,330
Net income	28,663	25,703	35,767	79,317
Net income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Net income attributable to MPT common stockholders	$ 28,537	$ 25,648	$ 35,575	$ 79,152
Earnings per common share / units - basic
Income from continuing operations attributable to MPT common stockholders \| $ / shares	$ 0.16	$ 0.16	$ 0.21	$ 0.51
Income (loss) from discontinued operations attributable to MPT common stockholders \| $ / shares				0.02
Net income attributable to MPT common stockholders \| $ / shares	0.16	0.16	0.21	0.53
Earnings per common share / units - diluted
Income from continuing operations attributable to MPT common stockholders \| $ / shares	0.16	0.16	0.21	0.51
Income (loss) from discontinued operations attributable to MPT common stockholders \| $ / shares				0.02
Net income attributable to MPT common stockholders \| $ / shares	$ 0.16	$ 0.16	$ 0.21	$ 0.53
Weighted average shares outstanding:
Basic \| shares	171,893	154,758	169,195	148,204
Diluted \| shares	172,639	155,969	169,852	149,517
Dividends declared per common share / unit \| $ / shares	$ 0.21	$ 0.20	$ 0.63	$ 0.60
MPT Operating Partnership, L.P. [Member]
Revenues
Rent billed	$ 48,063	$ 31,544	$ 136,952	$ 94,072
Straight-line rent	5,282	2,884	10,648	8,352
Income from direct financing leases	12,308	11,298	36,787	29,284
Interest and fee income	15,124	14,380	46,039	43,136
Total revenues	80,777	60,106	230,426	174,844
Expenses
Real estate depreciation and amortization	13,354	8,714	39,485	25,827
Impairment charges			50,128
Property-related	700	458	1,401	1,520
General and administrative	8,672	6,285	25,836	21,162
Acquisition expenses	4,886	4,179	7,933	6,457
Total operating expenses	27,612	19,636	124,783	54,966
Operating income	53,165	40,470	105,643	119,878
Other income (expense)
Interest and other income (expense)	75	3	44	(245)
Earnings from equity and other interests	1,153	843	2,059	2,511
Interest income (expense)	(25,481)	(15,830)	(71,455)	(45,896)
Debt refinancing costs			(290)
Income tax benefit (expense)	(249)	(94)	(232)	(261)
Net other expense	(24,502)	(15,078)	(69,874)	(43,891)
Income from continuing operations	28,663	25,392	35,769	75,987
Income (loss) from discontinued operations		311	(2)	3,330
Net income	28,663	25,703	35,767	79,317
Net income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Net income attributable to MPT common stockholders	$ 28,537	$ 25,648	$ 35,575	$ 79,152
Earnings per common share / units - basic
Income from continuing operations attributable to MPT common stockholders \| $ / shares	$ 0.16	$ 0.16	$ 0.21	$ 0.51
Income (loss) from discontinued operations attributable to MPT common stockholders \| $ / shares				0.02
Net income attributable to MPT common stockholders \| $ / shares	0.16	0.16	0.21	0.53
Earnings per common share / units - diluted
Income from continuing operations attributable to MPT common stockholders \| $ / shares	0.16	0.16	0.21	0.51
Income (loss) from discontinued operations attributable to MPT common stockholders \| $ / shares				0.02
Net income attributable to MPT common stockholders \| $ / shares	$ 0.16	$ 0.16	$ 0.21	$ 0.53
Weighted average shares outstanding:
Basic \| shares	171,893	154,758	169,195	148,204
Diluted \| shares	172,639	155,969	169,852	149,517
Dividends declared per common share / unit \| $ / shares	$ 0.21	$ 0.20	$ 0.63	$ 0.60

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net income	$ 28,663	$ 25,703	$ 35,767	$ 79,317
Other comprehensive income (loss):
Unrealized gain on interest rate swap	1,136	182	2,342	2,788
Foreign currency translation loss	(1,319)		(1,273)
Total comprehensive income	28,480	25,885	36,836	82,105
Comprehensive income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Comprehensive income attributable to MPT common stockholders (Operating Partnership partners)	28,354	25,830	36,644	81,940
MPT Operating Partnership, L.P. [Member]
Net income	28,663	25,703	35,767	79,317
Other comprehensive income (loss):
Unrealized gain on interest rate swap	1,136	182	2,342	2,788
Foreign currency translation loss	(1,319)		(1,273)
Total comprehensive income	28,480	25,885	36,836	82,105
Comprehensive income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Comprehensive income attributable to MPT common stockholders (Operating Partnership partners)	$ 28,354	$ 25,830	$ 36,644	$ 81,940

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities
Net income (loss)	$ 35,767	$ 79,317
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	40,403	27,000
Straight-line rent revenue	(11,599)	(8,260)
Straight-line rent write-off	950
Impairment charges	50,128
Direct financing lease interest accretion	(4,954)	(4,106)
Share-based compensation	6,571	6,019
Gain on sale of real estate		(2,054)
Amortization and write-off of deferred financing costs and debt discount	3,731	2,624
Other adjustments	1,175	4,156
Changes in:
Interest and rent receivable	(12,957)	(9,216)
Accounts payable and accrued expenses	(13,471)	6,084
Net cash provided by operating activities	95,744	101,564
Investing activities
Cash paid for acquisitions and other related investments	(182,982)	(371,500)
Principal received on loans receivable	8,381	4,694
Net proceeds from sale of real estate	34,649	18,409
Investments in loans receivable	(9,102)	(1,445)
Construction in progress and other	(97,002)	(63,422)
Net cash used for investing activities	(246,056)	(413,264)
Financing activities
Revolving credit facilities, net	(105,000)	(80,000)
Additions to term debt	425,000	153,000
Payments of term debt	(100,197)	(11,185)
Distributions paid	(108,026)	(87,928)
Proceeds from sale of common shares / units, net of offering costs	128,270	313,319
Lease deposits and other obligations to tenants	10,879	3,589
Debt issuance costs paid and other financing activities	(11,757)	(4,282)
Net cash provided by financing activities	239,169	286,513
Increase (decrease) in cash and cash equivalents for period	88,857	(25,187)
Effect of exchange rate changes	(2,024)
Cash and cash equivalents at beginning of period	45,979	37,311
Cash and cash equivalents at end of period	132,812	12,124
Interest paid	62,826	38,997
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	36,277	32,381
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income (loss)	35,767	79,317
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	40,403	27,000
Straight-line rent revenue	(11,599)	(8,260)
Straight-line rent write-off	950
Impairment charges	50,128
Direct financing lease interest accretion	(4,954)	(4,106)
Share-based compensation	6,571	6,019
Gain on sale of real estate		(2,054)
Amortization and write-off of deferred financing costs and debt discount	3,731	2,624
Other adjustments	1,175	4,156
Changes in:
Interest and rent receivable	(12,957)	(9,216)
Accounts payable and accrued expenses	(13,471)	6,084
Net cash provided by operating activities	95,744	101,564
Investing activities
Cash paid for acquisitions and other related investments	(182,982)	(371,500)
Principal received on loans receivable	8,381	4,694
Net proceeds from sale of real estate	34,649	18,409
Investments in loans receivable	(9,102)	(1,445)
Construction in progress and other	(97,002)	(63,422)
Net cash used for investing activities	(246,056)	(413,264)
Financing activities
Revolving credit facilities, net	(105,000)	(80,000)
Additions to term debt	425,000	153,000
Payments of term debt	(100,197)	(11,185)
Distributions paid	(108,026)	(87,928)
Proceeds from sale of common shares / units, net of offering costs	128,270	313,319
Lease deposits and other obligations to tenants	10,879	3,589
Debt issuance costs paid and other financing activities	(11,757)	(4,282)
Net cash provided by financing activities	239,169	286,513
Increase (decrease) in cash and cash equivalents for period	88,857	(25,187)
Effect of exchange rate changes	(2,024)
Cash and cash equivalents at beginning of period	45,979	37,311
Cash and cash equivalents at end of period	132,812	12,124
Interest paid	62,826	38,997
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	$ 36,277	$ 32,381

Organization	9 Months Ended
Organization	Sep. 30, 2014
Accounting Policies [Abstract]
Organization	1. Organization Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the Maryland General Corporation Law for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., (the “Operating Partnership”) through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist. We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRSs”). Our TRSs are subject to both U.S. federal and state income taxes. Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment. All of our properties are located in the United States and Europe.

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended September 30, 2014, are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. The condensed consolidated balance sheet at December 31, 2013 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2013. During the nine months ended September 30, 2014, there were no material changes to these policies, except as noted below with respect to discontinued operations.

Reclassifications: Certain reclassifications have been made to the condensed consolidated financial statements to conform to the 2014 consolidated financial statement presentation. These reclassifications had no impact on stockholders’ equity or net income.

Recent Accounting Developments: In 2014, the FASB issued Accounting Standards Update 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”), which raises the threshold for disposals to qualify as discontinued operations. A discontinued operation is defined as: (1) a component of an entity or group of components that has been disposed of or classified as held for sale and represents a strategic shift that has or will have a major effect on an entity’s operations and financial results; or (2) an acquired business that is classified as held for sale on the acquisition date. ASU 2014-08 also requires additional disclosures regarding discontinued operations, as well as material disposals that do not meet the definition of discontinued operations. We adopted ASU 2014-08 for the quarter ended March 31, 2014. The application of this guidance is prospective from the date of adoption and should result in our not generally having to reflect single property disposals as discontinued operations in the future.

In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to a customer at an amount reflecting the consideration it expects to receive in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. Additionally, this guidance requires improved disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is effective for the first interim period within annual reporting periods beginning after December 15, 2016, and early adoption is not permitted. We are currently in the process of evaluating the impact the adoption of ASU 2014-09 will have on our financial position and results of operations.

Variable Interest Entities

At September 30, 2014, we had loans to and/or equity investments in several variable interest entities (“VIEs”) for which we are not the primary beneficiary. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at September 30, 2014 (in thousands):


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	256,193	Mortgage and other loans	$	210,528
Equity investments	$	47,095	Other assets	$	5,293

(1)

Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rent receivables), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrower or investee) that most significantly impact the VIE’s economic performance. As of September 30, 2014, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls) except as discussed in Note 3 related to the debtor-in-possession financing commitment to Monroe.

Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Real Estate and Lending Activities

9 Months Ended

Sep. 30, 2014

Leases [Abstract]

Real Estate and Lending Activities

3. Real Estate and Lending Activities

Acquisitions

2014 Activity

On September 19, 2014, we acquired an acute care hospital in Fairmont, West Virginia for an aggregate purchase price of $15 million from Alecto Healthcare Services. The facility was simultaneously leased back to the seller under a 15-year initial term with three five-year extension options. In addition, we made a $5 million working capital loan to the tenant with a five year term and a commitment to fund up to $5 million in capital improvements.

On July 1, 2014, we acquired an acute care hospital in Peasedown St. John, United Kingdom from Circle Health Ltd., through its subsidiary Circle Hospital (Bath) Ltd. The sale/leaseback transaction, excluding any transfer taxes, is valued at approximately £28.3 million (approximately $48.0 million). The lease has an initial term of 15-years with a tenant option to extend the lease for an additional 15 years. The lease includes annual rent increases, which will equal the year-over-year change in the retail price index with a floor of 2% and a cap of 5%. With the transaction, we incurred approximately £1.1 (approximately $1.9 million) million of transfer and other taxes that have been expensed as acquisition costs.

On March 31, 2014, we acquired a general acute care hospital and an adjacent parcel of land for an aggregate purchase price of $115 million from a joint venture of LHP Hospital Group, Inc. and Hackensack University Medical Center Mountainside. The facility was simultaneously leased back to the seller under a lease with a 15-year initial term with a 3-year extension option, followed by a further 12-year extension option at fair market value. The lease provides for consumer price-indexed annual rent increases, subject to a specified floor and ceiling. The lease includes a customary right of first refusal with respect to a subsequent proposed sale of the facility.

2013 Activity

On September 26, 2013, we acquired three general acute care hospitals from affiliates of IASIS Healthcare LLC (“IASIS”) for a combined purchase price of $281.3 million. Each of the facilities were leased back to IASIS under leases with initial 15-year terms plus two renewal options of five years each, and consumer price-indexed rent increases limited to a 2.5% ceiling annually. The lessees have a right of first refusal option with respect to subsequent proposed sales of the facilities. All of our leases with affiliates of IASIS are cross-defaulted with each other. In addition to the IASIS acquisitions transactions, we amended our lease with IASIS for the Pioneer Valley Hospital in West Valley City, Utah, which extended the lease to 2028 from 2019 and adjusted the rent.

On July 18, 2013, we acquired the real estate of Esplanade Rehab Hospital in Corpus Christi, Texas (now operating as Corpus Christi Rehabilitation Hospital). The total purchase price was $10.5 million including $0.5 million for adjacent land. The facility is leased to an affiliate of Ernest Health Inc. (“Ernest”) under the master lease agreement entered into with Ernest in 2012 that initially provided for a 20-year term with three five-year extension options, plus consumer price-indexed rent increases, limited to a 2% floor and 5% ceiling annually. This lease is accounted for as a direct financing lease (“DFL”). In addition, we made a $5.3 million loan on this property with terms similar to the lease terms.

On June 11, 2013, we acquired the real estate of two acute care hospitals in Kansas from affiliates of Prime Healthcare Services, Inc. (“Prime”) for a combined purchase price of $75 million and leased the facilities to the operator under a master lease agreement. The master lease is for 10 years and contains two renewal options of five years each, and the rent increases annually based on the greater of the consumer price-index or 2%. This lease is accounted for as a DFL.

As part of these acquisitions, we acquired the following assets during the first nine months:


	2014		2013
Assets Acquired
Land	$	13,058	$	16,220
Building		152,096		265,030
Intangible lease assets — subject to amortization (weighted average useful life 15 years)		12,828		—
Net investments in direct financing leases		—		85,000
Other loans		5,000		5,250

Total assets acquired	$	182,982	$	371,500

The purchase price allocation attributable to the facilities acquired in 2014 along with the facilities acquired from RHM Klinik-und Altenheimbetriebe GmbH & Co. KG (“RHM”) in the 2013 fourth quarter is preliminary as we are waiting on additional information to perform our final analysis. When all relevant information is obtained, and if changes to our provisional purchase price allocations are needed, we will retrospectively adjust to reflect the new information obtained about the facts and circumstances that existed as of the respective acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date.

Development Activities

During the first nine months of 2014, we completed construction and began recording rental income on the following facilities:

•

Northern Utah Rehabilitation Hospital – This $19 million inpatient rehabilitation facility located in South Ogden, Utah is leased to Ernest pursuant to the 2012 master lease.

•

Oakleaf Surgical Hospital – This $30.5 million acute care facility located in Altoona, Wisconsin. This facility is leased to National Surgical Hospitals for 15 years and contains two renewal options of five years each plus additional option for nearly another five years, and the rent increases annually based on changes in the consumer price-index.

•

First Choice ER (a subsidiary of Adeptus Health) – We completed 16 acute care facilities for this tenant during 2014 totaling approximately $73.7 million. These facilities are leased pursuant to the master lease entered into in 2013.

On August 15, 2014 we executed a binding $8.7 million agreement with Health Care Authority for University of Alabama Birmingham (UAB) Medical West, an Affiliate of UAB Health System for the development of a freestanding emergency department and medical office building. The facilities will be leased to Medical West under 15 year initial lease terms with four extension options of five years each. We began construction on this facility in September 2014 and expect the facility to be completed in the second quarter of 2015.

On July 29, 2014, we executed a binding $150 million agreement with Adeptus Health for the development of acute care hospitals and free-standing emergency departments. These facilities will be leased to Adeptus Health pursuant to a new master lease agreement that has a 15-year initial term with three extension options of five years each that provides for annual rent increases based on changes in the consumer price index with a 2% minimum. This new master lease agreement is cross-defaulted with the original master lease executed with First Choice ER in 2013. We began construction on one of these facilities in the 2014 third quarter pursuant to the master funding and development agreement.

In regards to our Twelve Oaks facility, approximately 55% of this facility is being occupied, pursuant to a 15 year lease.

See table below for a status update on our current development projects (in thousands):

Property

Location

Property Type

Operator

Commitment

Costs Incurred
as of
September 30,
2014

Estimated
Completion
Date

First Choice ER—Commerce City

Denver, CO

Acute Care Hospital

Adeptus Health

5,372

1,924

4Q 2014

UAB Medical West

Hoover, AL

Acute Care Hospital & Medical Office Building

Medical West, an affiliate of UAB

8,653

257

2Q 2015

First Choice ER—Summerwood

Houston, TX

Acute Care Hospital

Adeptus Health

6,015

1,535

2Q 2015

First Choice – Various

Various

Acute Care Hospital

Adeptus Health

143,985

—

Various

164,025

3,716

Disposals

On May 20, 2014, the tenant of our Bucks facility gave notice of their intent to exercise the lease’s purchase option. Pursuant to this purchase option, the tenant acquired the facility on August 6, 2014 for $35 million. We wrote down this facility to fair market value less cost to sell, resulting in a $3.1 million real estate impairment charge in the 2014 second quarter. The sale of the Bucks facility is not a strategic shift in our operations, and therefore the results of the Bucks operations have not been reclassified as discontinued operations.

In April 2013, we sold two long-term acute care hospitals, Summit Hospital of Southeast Arizona and Summit Hospital of Southeast Texas, for total proceeds of $18.5 million, resulting in a gain of $2.1 million.

Leasing Operations

All of our leases are accounted for as operating leases except for the master lease of 13 Ernest facilities and five Prime facilities which are accounted for as DFLs. The components of our net investment in DFLs consisted of the following (dollars in thousands):


	As of September 30, 2014			As of December 31, 2013
Minimum lease payments receivable	$	1,615,867		$	1,647,567
Estimated residual values		212,266			211,863
Less: Unearned income		(1,391,747	)		(1,428,406	)

Net investment in direct financing leases	$	436,386		$	431,024

Monroe Facility

As of September 30, 2014 and December 31, 2013, our net investment (exclusive of the related real estate) in Monroe was as follows:


	As of September 30, 2014			As of December 31, 2013
Loans	$	35,443		$	31,341
Less: Loan impairment reserve		(32,943	)		(12,000	)

Loans, net		2,500			19,341
Interest, rent and other receivables		—			20,972

Net investment	$	2,500		$	40,313

The current operator of our Monroe facility has not made all payments required by the real estate lease agreement and working capital loan agreement, and we have deemed these assets to be impaired. During 2010, we recorded a $12 million impairment charge on the working capital loan and fully reserved for unbilled straight-line rent receivables as well. Since 2010, we have not recognized any interest income on the Monroe loan and have not recorded any unbilled rent revenue. In addition, we stopped recording billed rental revenue on April 1, 2013.

During the first quarter of 2014, we executed a non-binding letter of intent with a third party with respect to a restructuring of our investment in the form of a new joint venture that would acquire the real estate of our Monroe facility and related assets in exchange for a combination of cash and promissory notes along with the potential of additional cash, if any, to be generated from our share in this new joint venture’s operations. Based on those new developments and the fair value of the loan’s underlying collateral at that time (using Level 2 inputs), we recorded an approximate $20.5 million impairment charge in the 2014 first quarter. Subsequent to the 2014 first quarter, we terminated this non-binding letter of intent.

In July 2014, we entered into an agreement with Prime to manage the Monroe Hospital. In addition, we entered into a non-binding letter of intent with Prime to lease the facility for initial cash rents of $2.1 million. These agreements contemplate a bankruptcy filing by the existing tenant and do not provide us with any recovery on the past due receivables. Based on these new developments and the fair value of our real estate and the underlying collateral of our loan (using Level 2 inputs), we recorded a $26.5 million impairment charge in the 2014 second quarter. As of September 30, 2014, the bankruptcy of the existing tenant is progressing as planned. In July 2014, the new third party, Prime, was awarded the operations of the Monroe facility, and we expect for them to take over operations and begin leasing the facility from us in the near term. As part of the bankruptcy process, we agreed to provide up to $5 million in debtor-in-possession financing of which we have provided $2.5 million as of September 30, 2014 and another $1 million on October 31, 2014. At September 30, 2014, our investment in Monroe is $27.5 million which we believe is fully recoverable. However, no assurances can be made that we will not have additional impairment charges in the future.

Florence facility

On March 6, 2013, the tenant of our facility in Phoenix, Arizona filed for Chapter 11 bankruptcy. At September 30, 2014, we have approximately $1 million of outstanding receivables but the tenant continues to pay us in accordance with bankruptcy orders. We have a letter of credit for approximately $1.2 million to cover any rent and other monetary payments not made. Although no assurances can be made that we will not have any impairment charges in the future, we believe our real estate investment in Florence of $27.6 million at September 30, 2014, is fully recoverable.

Gilbert facility

In the first quarter of 2014, the tenant of our facility in Gilbert, Arizona filed for Chapter 11 bankruptcy; however, we sent notice of termination of the lease prior to the bankruptcy filing. As a result of the lease terminating, we recorded a charge of approximately $1 million to reserve against the straight-line rent receivables. In addition, we accelerated the amortization of the related lease intangible asset resulting in $1.1 million of additional expense in the 2014 first quarter. At September 30, 2014, we have $0.1 million of outstanding receivables, which we believe are collectible. Although no assurances can be made that we will not have any impairment charges or write-offs of receivables in the future, we believe our real estate investment in Gilbert of $14.2 million at September 30, 2014, is fully recoverable.

Loans

The following is a summary of our loans (in thousands):


	As of September 30, 2014		As of December 31, 2013
Mortgage loans	$	385,093	$	388,756
Acquisition loans		108,028		109,655
Working capital and other loans		36,038		47,983
Convertible loan		3,352		3,352

	$	532,511	$	549,746

The decrease in our working capital and other loans is primarily due to the impairment charge incurred on our Monroe loan during 2014 (– see Note 3, Leasing Operations for further discussion) partially offset by new loans or advances made.

On March 1, 2012, pursuant to our convertible note agreement, we converted $1.7 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At September 30, 2014, $3.3 million remains outstanding on the convertible note, and we retain the option, subject to regulatory approvals, to convert this remainder into 15.1% of equity interest in the operator.

Concentrations of Credit Risk

For the three months ended September 30, 2014 and 2013, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 26.4% and 33.9%, respectively, of total revenue. For the nine months ended September 30, 2014 and 2013, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 27.8% and 32.6%, respectively, of total revenue. From an investment concentration perspective, Prime represented 22.5% and 24.5% of our total assets at September 30, 2014 and December 31, 2013, respectively.

For the three months ended September 30, 2014 and 2013, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 18.3% and 20.8%, respectively, of total revenue. For the nine months ended September 30, 2014 and 2013, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 18.7% and 20.6%, respectively, of total revenue. From an investment concentration perspective, Ernest represented 15.3% and 15.9% of our total assets at September 30, 2014 and December 31, 2013, respectively.

On an individual property basis, we had no investment of any single property greater than 4% of our total assets as of September 30, 2014.

From a geographic perspective, investments located in California represented 17.2% of our total assets at September 30, 2014, down from 18.7% at December 31, 2013. Investments located in Texas represented 22.5% of our total assets at September 30, 2014, down slightly from 22.7% at December 31, 2013. In addition, we further expanded our portfolio into Europe with the RHM portfolio acquisition in 2013 and the Circle (Bath) acquisition this quarter, which represents less than 9% of total assets at September 30, 2014.

Debt

9 Months Ended

Sep. 30, 2014

Debt Disclosure [Abstract]

Debt

4. Debt

The following is a summary of our debt (dollar amounts in thousands):


	As of September 30, 2014					As of December 31, 2013
	Balance		Interest Rate			Balance		Interest Rate
Revolving credit facility	$	—		Variable		$	105,000		Variable
2006 Senior Unsecured Notes		125,000		Various			125,000		Various
2011 Senior Unsecured Notes		450,000		6.875	%		450,000		6.875	%
2012 Senior Unsecured Notes:
Principal amount		350,000		6.375	%		350,000		6.375	%
Unamortized premium		2,610		—			2,873		—

		352,610					352,873
2013 Senior Unsecured Notes (A)		252,620		5.750	%		274,860		5.750	%
2014 Senior Unsecured Notes		300,000		5.500	%		—		—
Term loans		138,751		Various			113,948		Various

	$	1,618,981				$	1,421,681

(A)	These notes are Euro-denominated and reflect the exchange rates at September 30, 2014 and December 31, 2013, respectively.

As of September 30, 2014, principal payments due for our debt (which exclude the effects of any premiums recorded) are as follows (in thousands):


2014	$	69
2015		283
2016		125,298
2017		320
2018		12,781
Thereafter		1,477,620

Total	$	1,616,371

Credit Facility

On June 19, 2014, we closed on a new $900 million senior unsecured credit facility (the “Credit Facility”). The Credit Facility is comprised of a $775 million senior unsecured revolving credit facility (the “Revolving credit facility”) and a $125 million senior unsecured term loan facility (the “Term Loan”). The Credit Facility has an accordion feature that allows us to expand the size of the facility by up to $250 million through increases to the Revolving credit facility, Term Loan, both or as a separate term loan tranche (See Note 11 for further update on the accordion feature). The Credit Facility replaced our existing $400 million unsecured revolving credit facility and $100 million unsecured term loan. This transaction resulted in a refinancing charge of approximately $0.3 million in the 2014 second quarter.

On October 17, 2014, we exercised the $250 million accordion to the Credit Facility which increased the current aggregate committed size of the facility to $1.15 billion. In addition, we negotiated for a new accordion of up to $400 million, for total aggregate capacity of $1.55 billion. We also amended the Credit Facility to increase the alternative currency sublimit to €500 million and certain covenants in order to permit us to consummate and finance the Median transactions, as described in Note 11.

The Revolving credit facility matures in June 2018 and can be extended for an additional 12 months at our option. The Revolving credit facility’s interest rate is (1) the higher of the “prime rate”, federal funds rate plus 0.50%, or Eurodollar rate plus 1.00%, plus a spread initially set at 1.00%, but that is adjustable from 0.70% to 1.25% based on current total leverage, or (2) LIBOR

plus a spread initially set at 2.00%, but that is adjustable from 1.70% to 2.25% based on current total leverage. The pricing grid for the Revolving credit facility may be further adjusted subject to an investment grade rating being obtained. In addition to interest expense, we are required to pay a quarterly commitment fee on the undrawn portion of the revolving credit facility, ranging from 0.25% to 0.35% per year. At September 30, 2014, we had no borrowings outstanding on the Revolving credit facility.

The Term Loan matures in June 2019. The Term Loan’s interest rate is (1) the higher of the “prime rate”, federal funds rate plus 0.50%, or Eurodollar rate plus 1.00%, plus a spread initially set at 0.95%, but that is adjustable from 0.60% to 1.20% based on current total leverage, or (2) LIBOR plus a spread initially set at 1.95%, but that is adjustable from 1.60% to 2.20% based on current total leverage. The pricing grid for the Term Loan may be similarly adjusted subject to an investment grade rating being obtained. At September 30, 2014, the interest rate in effect was 2.11%.

2014 Senior Unsecured Notes

On April 17, 2014, we completed a $300 million senior unsecured notes offering (“2014 Senior Unsecured Notes”). Interest on the notes will be payable semi-annually on May 1 and November 1 of each year, commencing on November 1, 2014. The 2014 Senior Unsecured Notes will pay interest in cash at a rate of 5.50% per year. The notes mature on May 1, 2024. We may redeem some or all of the 2014 Senior Unsecured Notes at any time prior to May 1, 2019 at a “make-whole” redemption price. On or after May 1, 2019, we may redeem some or all of the notes at a premium that will decrease over time. In addition, at any time and from time to time prior to May 1, 2017, we may redeem up to 35% of the aggregate principal amount of the 2014 Senior Unsecured Notes using the proceeds of one or more equity offerings. The 2014 Senior Unsecured Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by certain subsidiary guarantors. In the event of a change of control, each holder of the 2014 Senior Unsecured Notes may require us to repurchase some or all of our 2014 Senior Unsecured Notes at a repurchase price equal to 101% of the aggregate principal amount of the 2014 Senior Unsecured Notes plus accrued and unpaid interest to the date of purchase.

Interest Rate Swap

During the second quarter 2010, we entered into an interest rate swap to manage our exposure to variable interest rates by fixing $65 million of our 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. The fair value of the interest rate swaps was $6.7 million and $9.0 million as of September 30, 2014 and December 31, 2013, respectively, which is reflected in accounts payable and accrued expenses on the consolidated balance sheets.

We designated our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effect earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness in the periods; therefore, there was no income statement effect recorded during the three and nine month periods ended September 30, 2014 or 2013. We do not expect any of the current losses included in accumulated other comprehensive loss to be reclassified into earnings in the next 12 months. At September 30, 2014 and December 31, 2013, we had $3.5 million and $5.0 million, respectively, posted as collateral, which is currently reflected in other assets on our consolidated balance sheets.

Covenants

Our debt facilities impose certain restrictions on us, including, but not limited to, restrictions on our ability to: incur debt; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreement governing our Credit Facility limit the amount of dividends we can pay to 95% of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis. The indentures governing our 2011, 2012, 2013 and 2014 Senior Unsecured Notes also limit the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our 2011, 2012, 2013 and 2014 Senior Unsecured Notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.

In addition to these restrictions, the Credit Facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, secured leverage ratio, unsecured leverage ratio, consolidated adjusted net worth, and unsecured interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At September 30, 2014, we were in compliance with all such financial and operating covenants.

Common Stock/Partners' Capital	9 Months Ended
Common Stock/Partners' Capital	Sep. 30, 2014
Equity [Abstract]
Common Stock/Partners' Capital	5. Common Stock/Partners’ Capital Medical Properties Trust, Inc. On March 11, 2014, we completed an underwritten public offering of 7.7 million shares of our common stock, resulting in net proceeds of approximately $100.2 million, after deducting estimated offering expenses. We also granted the underwriters a 30-day option to purchase up to an additional 1.2 million shares of common stock. The option, which was exercised in full, closed on April 8, 2014 and resulted in additional net proceeds of approximately $16 million. In January 2014, we put an at-the-market equity offering program in place, giving us the ability to sell up to $250 million of stock with a commission of 1.25%. During the first nine months of 2014, we sold 0.9 million shares of our common stock under our at-the-market equity offering program, at an average price of $13.21 per share resulting in total proceeds, net of commission, of $12.3 million. On August 20, 2013, we completed an offering of 11.5 million shares of common stock (including 1.5 million shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares) at a price of $12.75 per share, resulting in net proceeds (after underwriting discount and expenses) of $140.4 million. On February 28, 2013, we completed an offering of 12.7 million shares of our common stock (including 1.7 million shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares) at a price of $14.25 per share, resulting in net proceeds (after underwriting discount and expenses) of $172.9 million. MPT Operating Partnership, L.P. At September 30, 2014, the Company has a 99.9% ownership interest in the Operating Partnership with the remainder owned by three other partners, two of whom are employees and one of whom is a director. During the nine months ended September 30, 2014 and 2013, the partnership issued 9.8 million and 24.2 million units, respectively, in direct response to the common stock offerings by Medical Properties Trust, Inc.

Stock Awards	9 Months Ended
Stock Awards	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Awards	6. Stock Awards We adopted the 2013 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2013, which authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,643,651 shares of common stock for awards under the Equity Incentive Plan for which 6,436,291 shares remain available for future stock awards as of September 30, 2014. We awarded the following during the nine months ended September 2014 and 2013: Time-based awards—We granted 345,984 and 258,736 shares in 2014 and 2013, respectively, of time-based restricted stock to management, independent directors and certain employees. These awards vest quarterly based on service, over three years, in equal amounts. Performance-based awards—Our management team and certain employees were awarded 324,754 and 222,566 of performance based awards in 2014 and 2013, respectively. These awards vest ratably over a three year period based on the achievement of certain total shareholder return measures, with a carry-back and carry-forward provision through December 31, 2017 (for the 2013 awards) and December 31, 2018 (for the 2014 awards). Dividends on these awards are paid only upon achievement of the performance measures. Multi-year Performance-based awards—We awarded 500,000 and 550,000 shares in 2014 and 2013, respectively, of multi-year performance-based awards to management. These shares are subject to three-year cumulative performance hurdles based on measures of total shareholder return. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

7. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and working capital loans are estimated by using Level 2 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our 2011, 2012, 2013 and 2014 Senior Unsecured Notes, using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our 2006 Senior Unsecured Notes, revolving credit facility, and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be possible and may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands):


	September 30, 2014						December 31, 2013
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	50,240		$	44,091		$	58,565		$	44,415
Loans (1)		335,061			350,770			351,713			358,383
Debt, net		(1,618,981	)		(1,698,142	)		(1,421,681	)		(1,486,090	)

(1)	Excludes loans related to Ernest since they are recorded at fair value and discussed below.

Items Measured at Fair Value on a Recurring Basis

Our equity interest in Ernest and related loans, which were acquired in 2012, are being measured at fair value on a recurring basis as we elected to account for these investments using the fair value option method. We have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans.

At September 30, 2014, these amounts were as follows (in thousands):


Asset Type	Fair Value		Cost		Asset Type Classification
Mortgage loans	$	100,000	$	100,000		Mortgage loans
Acquisition loans		97,450		97,450		Other loans
Equity investments		3,300		3,300		Other assets

	$	200,750	$	200,750

Our mortgage loans with Ernest are recorded at fair value based on Level 3 inputs by discounting the estimated cash flows using the market rates which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our acquisition loans and equity investments in Ernest are recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecast assumptions associated with the investee. We classify these loans and equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to the absence of quoted market prices. For these cash flow models, our observable inputs include use of a capitalization rate, discount rate (which is based on a weighted-average cost of capital), and market interest rates, and our unobservable input includes an adjustment for a marketability discount (“DLOM”) on our equity investment of 40% at September 30, 2014.

In regards to the underlying projection of revenues and expenses used in the discounted cash flow model, such projections are provided by Ernest. However, we will modify such projections (including underlying assumptions used) as needed based on our review and analysis of Ernest’s historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry.

In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):


Basis Point Change in Marketability Discount	Estimated Increase (Decrease) In Fair Value
+100 basis points	$	(442	)
- 100 basis points		442

Because the fair value of Ernest investments noted above approximate their original cost, we did not recognize any unrealized gains/losses during the first nine months of 2014.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Discontinued Operations

9 Months Ended

Sep. 30, 2014

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

8. Discontinued Operations

The following table presents the results of discontinued operations, which include the revenue and expenses of facilities disposed of in 2013, for the three and nine months ended September 30, 2014 and 2013 (dollar amounts in thousands except per share/unit amounts):


	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2014		2013		2014			2013
Revenues	$	—	$	387	$	—		$	1,625
Gain on sale		—		—		—			2,054
Income		—		311		(2	)		3,330
Earnings per share/unit — diluted	$	—	$	—	$	—		$	0.02

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

+ Details

Earnings Per Share/Common Unit

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Earnings Per Share/Common Unit

9. Earnings Per Share/Common Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (amounts in thousands):


	For the Three Months Ended September 30,
	2014			2013
Numerator:
Income from continuing operations	$	28,663		$	25,392
Non-controlling interests’ share in continuing operations		(126	)		(55	)
Participating securities’ share in earnings		(179	)		(166	)

Income from continuing operations, less participating securities’ share in earnings		28,358			25,171
Income from discontinued operations attributable to MPT common stockholders		—			311

Net income, less participating securities’ share in earnings	$	28,358		$	25,482

Denominator:
Basic weighted-average common shares		171,893			154,758
Dilutive potential common shares		746			1,211

Dilutive weighted-average common shares		172,639			155,969


	For the Nine Months Ended September 30,
	2014			2013
Numerator:
Income from continuing operations	$	35,769		$	75,987
Non-controlling interests’ share in continuing operations		(192	)		(165	)
Participating securities’ share in earnings		(584	)		(538	)

Income from continuing operations, less participating securities’ share in earnings		34,993			75,284
Income (loss) from discontinued operations attributable to MPT common stockholders		(2	)		3,330

Net income, less participating securities’ share in earnings	$	34,991		$	78,614

Denominator:
Basic weighted-average common shares		169,195			148,204
Dilutive potential common shares		657			1,313

Dilutive weighted-average common shares		169,852			149,517

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (amounts in thousands):


	For the Three Months Ended September 30,
	2014			2013
Numerator:
Income from continuing operations	$	28,663		$	25,392
Non-controlling interests’ share in continuing operations		(126	)		(55	)
Participating securities’ share in earnings		(179	)		(166	)

Income from continuing operations, less participating securities’ share in earnings		28,358			25,171
Income from discontinued operations attributable to MPT Operating Partnership partners		—			311

Net income, less participating securities’ share in earnings	$	28,358		$	25,482

Denominator:
Basic weighted-average units		171,893			154,758
Dilutive potential units		746			1,211

Dilutive weighted-average units		172,639			155,969


	For the Nine Months Ended September 30,
	2014			2013
Numerator:
Income from continuing operations	$	35,769		$	75,987
Non-controlling interests’ share in continuing operations		(192	)		(165	)
Participating securities’ share in earnings		(584	)		(538	)

Income from continuing operations, less participating securities’ share in earnings		34,993			75,284
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners		(2	)		3,330

Net income, less participating securities’ share in earnings	$	34,991		$	78,614

Denominator:
Basic weighted-average units		169,195			148,204
Dilutive potential units		657			1,313

Dilutive weighted-average units		169,852			149,517

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	10. Commitments and Contingencies Contingencies We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2014
Subsequent Events [Abstract]
Subsequent Events	11. Subsequent Events Median Acquisition and Financing On October 15, 2014, we entered into definitive agreements pursuant to which we will acquire substantially all the real estate assets of Median Kliniken S.à r.l. (“Median”), a German provider of post-acute and acute rehabilitation services, for an aggregate purchase price that is expected to be approximately €705 million, (or $900 million). The portfolio includes 38 rehabilitation hospitals and two acute care hospitals located across 12 states in the Federal Republic of Germany. We expect to consummate the transaction through a two step process in partnership with affiliates of Waterland Private Equity Fund V C.V. (“Waterland”). In the first step, an affiliate of Waterland will acquire 94.9% of the outstanding equity interest in Median pursuant to a stock purchase agreement with Median’s current owners. We will indirectly acquire the remaining 5.1% of the outstanding equity interest and provide interim loans in aggregate amounts up to the expected purchase price of the real estate assets. The consummation of the Median acquisition is subject to customary closing conditions, including German antitrust clearance. The loans we make will bear interest at a rate similar to the initial lease rate under the sale and leaseback transactions described below. Concurrently with or as soon as practical following the closing of the Median acquisition, we will acquire substantially all of Median’s real estate assets under a sale and leaseback agreement. We will either assume or novate any third party debt attributable to the real estate assets or provide the cash required to repay the third party debt. The purchase price we are required to pay for the real estate assets will be offset, pro rata, against amounts of debt that we assume or have provided cash to repay, and/or against the amounts of loans previously made. The sale and leaseback transactions are conditioned on the acquisition of Median described above and is also subject to customary real estate, regulatory and other closing conditions, including waiver of any statutory pre-emption rights by local municipalities. To the extent we are unable to acquire the entire Median portfolio as contemplated, we will have a right of first refusal with regard to any new real estate properties owned or acquired by Median. Upon our acquisition of the real estate assets, we will lease them back to Median under a 27 year master lease, with annual escalators at the greater of one percent or 70% of the German consumer price index. We expect the transactions to be completed during the first quarter of 2015. An affiliate of Waterland controls RHM, the operator and lessee of the German facilities that we currently own. Subject to prevailing market conditions, we intend to finance the Median transactions with the assumption of existing mortgage debt on the facilities, net proceeds of borrowings under our Credit Facility, new secured and unsecured debt issuances, equity issuances, or a combination thereof. On October 17, 2014, we exercised the $250 million accordion to our existing Credit Facilty which increased the current aggregate committed size of the facility to $1.15 billion. In addition, we negotiated for a new accordion of up to $400 million, for total aggregate capacity of $1.55 billion. We also amended the Credit Facility to increase the alternative currency sublimit to €500 million and certain covenants in order to permit us to consummate and finance the Median transactions. Finally, we have received a commitment letter from J.P. Morgan, pursuant to which JPM and a syndicate of lenders have agreed to fund a new one-year senior unsecured term loan of up to $225 million. The commitment letter is subject to customary conditions for this this type of financing, including, but not limited to, consummation of the Median transactions. The commitment letter provides that, subject to certain exceptions, the commitment will be reduced by the amount of additional debt and equity capital that we raise (or if the term loan is then funded we will be obligated to repay the term loan in such amount). Other Acquisitions and Financing On October 31, 2014, we acquired a 237-bed acute care hospital, four medical office buildings and a behavioral health facility in Sherman, Texas for $32.5 million. Alecto Healthcare Services is the tenant and operator pursuant to a 15-year lease agreement with three five-year extension options. In addition we agreed to fund a working capital loan up to $7.5 million, of which $3 million was funded on October 31, 2014. On September 18, 2014, we entered into definitive agreements to acquire three RHM rehabilitation facilities in Germany for an aggregate purchase price of €63.6 million (approximately $81 million). These facilities include: Bad Mergentheim (211 beds), Bad Tolz (248 beds), and Bad Liebenstein (271 beds). All three properties will be included under our existing master lease agreement with RHM. On November 4, 2014, we closed on the Bad Liebenstein facility and expect to close on the other two facilities in the 2014 fourth quarter. During November 2014, we sold 0.8 million shares of our common stock under our at-the-market equity offering program, at an average price of $13.62 per share resulting in net proceeds of $10.3 million.

Condensed Consolidating Financial Information

9 Months Ended

Sep. 30, 2014

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Consolidating Financial Information

12. Condensed Consolidating Financial Information

The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. (“Parent” and a guarantor to our 2011, 2012, 2013 and 2014 Senior Unsecured Notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation (“Subsidiary Issuers”), (c) on a combined basis, the guarantors of our 2011, 2012, 2013 and 2014 Senior Unsecured Notes (“Subsidiary Guarantors”), and (d) on a combined basis, the non-guarantor subsidiaries (“Non-Guarantor Subsidiaries”). Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is joint and several, and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent’s ability to obtain funds from its subsidiaries by dividend or loan.

The guarantees by the Subsidiary Guarantors may be released and discharged upon: (1) any sale, exchange or transfer of all of the capital stock of a Subsidiary Guarantor; (2) the merger or consolidation of a Subsidiary Guarantor with a Subsidiary Issuer or any other Subsidiary Guarantor; (3) the proper designation of any Subsidiary Guarantor by the Subsidiary Issuers as “unrestricted” for covenant purposes under the indenture governing the 2011, 2012, 2013 and 2014 Senior Unsecured Notes; (4) the legal defeasance or covenant defeasance or satisfaction and discharge of the indenture; (5) a liquidation or dissolution of a Subsidiary Guarantor permitted under the indenture governing the 2011, 2012, 2013 and 2014 Senior Unsecured Notes; or (6) the release or discharge of the Subsidiary Guarantor from its guarantee obligations under our revolving credit facility.

Subsequent to September 30, 2013, certain of our subsidiaries were re-designated as non-guarantors of our 2011, 2012, 2013 and 2014 Senior Unsecured Notes as the underlying properties were sold in 2013 or related mortgage loans paid off in 2014. In addition, certain of our subsidiaries previously classified as non-guarantors are guarantors as of September 30, 2014. With these re-designations, we have restated the 2013 consolidating financial information below to reflect these changes.

Condensed Consolidated Balance Sheet

September 30, 2014

(in thousands)


	Parent		Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	—		$	1,995,236		$	65,947		$	—		$	2,061,183
Mortgage loans		—		—			285,093			100,000			—			385,093
Net investment in direct financing leases		—		—			214,709			221,677			—			436,386

Gross investment in real estate assets		—		—			2,495,038			387,624			—			2,882,662
Accumulated depreciation and amortization		—		—			(181,739	)		(9,543	)		—			(191,282	)
Net investment in real estate assets		—		—			2,313,299			378,081			—			2,691,380
Cash and cash equivalents		—		108,105			23,786			921			—			132,812
Interest and rent receivables		—		791			19,198			30,251			—			50,240
Straight-line rent receivables		—		—			44,633			11,770			—			56,403
Other loans		—		—			1,100			146,318			—			147,418
Net intercompany receivable		35,839		1,968,462			—			—			(2,004,301	)		—
Investment in subsidiaries		1,407,495		930,769			41,772			—			(2,380,036	)		—
Other assets		—		44,516			744			45,627			—			90,887

Total Assets	$	1,443,334	$	3,052,643		$	2,444,532		$	612,968		$	(4,384,337	)	$	3,169,140

Liabilities and Equity
Liabilities
Debt, net	$	—	$	1,605,230		$	—		$	13,751		$	—		$	1,618,981
Accounts payable and accrued expenses		36,229		40,235			8,265			697			—			85,426
Net intercompany payable		—		—			1,593,090			411,212			(2,004,302	)		—
Deferred revenue		—		214			24,432			6,184			—			30,830
Lease deposits and other obligations to tenants		—		(531	)		23,097			4,231			—			26,797

Total liabilities		36,229		1,645,148			1,648,884			436,075			(2,004,302	)		1,762,034
Total equity		1,407,105		1,407,495			795,648			176,893			(2,380,035	)		1,407,106

Total Liabilities and Equity	$	1,443,334	$	3,052,643		$	2,444,532		$	612,968		$	(4,384,337	)	$	3,169,140

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	69		$	45,703		$	6,424		$	(4,133	)	$	48,063
Straight-line rent		—			—			3,850			1,432			—			5,282
Income from direct financing leases		—			—			11,695			5,921			(5,308	)		12,308
Interest and fee income		—			9,323			14,336			7,338			(15,873	)		15,124

Total revenues		—			9,392			75,584			21,115			(25,314	)		80,777
Expenses
Real estate depreciation and amortization		—			—			12,814			540			—			13,354
Impairment charges		—			—			—			—			—			—
Property-related		—			169			732			9,171			(9,372	)		700
General and administrative		—			5,448			303			2,921			—			8,672
Acquisition expenses		—			469			1,929			2,488			—			4,886

Total operating expenses		—			6,086			15,778			15,120			(9,372	)		27,612

Operating income (expense)		—			3,306			59,806			5,995			(15,942	)		53,165
Other income (expense)
Other income (expense)		—			75			—			—			—			75
Earnings from equity and other interests		—			—			—			1,153			—			1,153
Interest income (expense)		—			(25,400	)		(8,304	)		(7,719	)		15,942			(25,481	)
Debt refinancing costs		—			—			—			—			—			—
Income tax benefit expense		—			—			(49	)		(200	)		—			(249	)

Net other income (expense)		—			(25,325	)		(8,353	)		(6,766	)		15,942			(24,502	)

Income (loss) from continuing operations		—			(22,019	)		51,453			(771	)		—			28,663
Income (loss) from discontinued operations		—			—			—			—			—			—
Equity in earnings of consolidated subsidiaries net of income taxes		28,663			50,682			995			—			(80,340	)		—

Net income		28,663			28,663			52,448			(771	)		(80,340	)		28,663
Net income (loss) attributable to non-controlling interests		(126	)		(126	)		—			—			126			(126	)

Net income attributable to MPT common stockholders	$	28,537		$	28,537		$	52,448		$	(771	)	$	(80,214	)	$	28,537

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	69		$	129,167		$	19,431		$	(11,715	)	$	136,952
Straight-line rent		—			—			7,881			2,767			—			10,648
Income from direct financing leases		—			—			34,956			17,691			(15,860	)		36,787
Interest and fee income		—			27,815			43,199			22,631			(47,606	)		46,039

Total revenues		—			27,884			215,203			62,520			(75,181	)		230,426
Expenses
Real estate depreciation and amortization		—			—			37,556			1,929			—			39,485
Impairment charges		—			289			19,002			30,837			—			50,128
Property-related		—			508			926			27,474			(27,507	)		1,401
General and administrative		—			22,096			560			3,180			—			25,836
Acquisition expenses		—			3,355			2,091			2,487			—			7,933

Total operating expenses		—			26,248			60,135			65,907			(27,507	)		124,783

Operating income (expense)		—			1,636			155,068			(3,387	)		(47,674	)		105,643
Other income (expense)
Other income (expense)		—			44			—			—			—			44
Earnings from equity and other interests		—			—			—			2,059			—			2,059
Interest income (expense)		—			(71,944	)		(24,836	)		(22,349	)		47,674			(71,455	)
Debt refinancing costs		—			(290	)		—			—			—			(290	)
Income tax benefit (expense)		—			—			(16	)		(216	)		—			(232	)

Net other income (expense)		—			(72,190	)		(24,852	)		(20,506	)		47,674			(69,874	)

Income (loss) from continuing operations		—			(70,554	)		130,216			(23,893	)		—			35,769
Income from discontinued operations		—			—			—			(2	)		—			(2	)
Equity in earnings of consolidated subsidiaries, net of income taxes		35,767			106,321			3,158			—			(145,246	)		—

Net income		35,767			35,767			133,374			(23,895	)		(145,246	)		35,767
Net income (loss) attributable to non-controlling interests		(192	)		(192	)		—			—			192			(192	)

Net income attributable to MPT common stockholders	$	35,575		$	35,575		$	133,374		$	(23,895	)	$	(145,054	)	$	35,575

Condensed Consolidated Statements of Comprehensive Income

For the Three Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Net income (loss)	$	28,663		$	28,663		$	52,448	$	(771	)	$	(80,340	)	$	28,663
Other comprehensive income (loss):
Unrealized gain on interest rate swap		1,136			1,136			—		—			(1,136	)		1,136
Foreign currency translation gain (loss)		(1,319	)		(1,319	)		—		—			1,319			(1,319	)

Total comprehensive income		28,480			28,480			52,448		(771	)		(80,157	)		28,480
Comprehensive income attributable to non-controlling interests		(126	)		(126	)		—		—			126			(126	)

Comprehensive income attributable to MPT common stockholders	$	28,354		$	28,354		$	52,448	$	(771	)	$	(80,031	)	$	28,354

Condensed Consolidated Statements of Comprehensive Income

For the Nine Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Net income (loss)	$	35,767		$	35,767		$	133,374	$	(23,895	)	$	(145,246	)	$	35,767
Other comprehensive income (loss):
Unrealized gain on interest rate swap		2,342			2,342			—		—			(2,342	)		2,342
Foreign currency translation gain (loss)		(1,273	)		(1,273	)		—		—			1,273			(1,273	)

Total comprehensive income		36,836			36,836			133,374		(23,895	)		(146,315	)		36,836
Comprehensive income attributable to non-controlling interests		(192	)		(192	)		—		—			192			(192	)

Comprehensive income attributable to MPT common stockholders	$	36,644		$	36,644		$	133,374	$	(23,895	)	$	(146,123	)	$	36,644

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(98	)	$	(76,425	)	$	221,310		$	(49,043	)	$	—		$	95,744
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(182,982	)		—			—			(182,982	)
Principal received on loans receivable		—			—			—			8,381			—			8,381
Net proceeds from sale of real estate		—			—			—			34,649			—			34,649
Investments in loans receivable		—			—			—			(9,102	)		—			(9,102	)
Construction in progress and other		—			(1,030	)		(95,489	)		(483	)		—			(97,002	)
Net cash provided by (used in) investing activities		—			(1,030	)		(278,471	)		33,445			—			(246,056	)
Financing Activities
Revolving credit facilities, net		—			(105,000	)		—			—			—			(105,000	)
Additions to term debt, net of discount		—			425,000			—			—			—			425,000
Payments of term debt		—			(100,176	)		—			(21	)		—			(100,197	)
Distributions paid		(107,842	)		(108,026	)		—			—			107,842			(108,026	)
Proceeds from sale of common shares/units, net of offering costs		128,270			128,270			—			—			(128,270	)		128,270
Lease deposits and other obligations to tenants		—			(360	)		9,431			1,808			—			10,879
Net payments relating to intercompany financing		(20,330	)		(61,206	)		46,446			14,662			20,428			—
Debt issuance costs paid and other financing activities		—			(11,757	)		—			—			—			(11,757	)

Net cash provided by financing activities		98			166,745			55,877			16,449			—			239,169

Increase (decrease) in cash and cash equivalents for period		—			89,290			(1,284	)		851			—			88,857
Effects of exchange rate changes on cash		—			—			(2,024	)		—			—			(2,024	)
Cash and cash equivalents at beginning of period		—			18,815			27,094			70			—			45,979

Cash and cash equivalents at end of period	$	—		$	108,105		$	23,786		$	921		$	—		$	132,812

Condensed Consolidated Balance Sheet

December 31, 2013

(in thousands)


	Parent		Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	—		$	1,796,415		$	69,040		$	—		$	1,865,455
Mortgage loans		—		—			285,106			103,650			—			388,756
Net investment in direct financing leases		—		—			212,543			218,481			—			431,024

Gross investment in real estate assets		—		—			2,294,064			391,171			—			2,685,235
Accumulated depreciation and amortization		—		—			(151,624	)		(8,152	)		—			(159,776	)

Net investment in real estate assets		—		—			2,142,440			383,019			—			2,525,459
Cash and cash equivalents		—		18,815			27,094			70			—			45,979
Interest and rent receivables		—		336			31,492			26,737			—			58,565
Straight-line rent receivables		—		—			37,015			8,814			—			45,829
Other loans		—		178			1,100			159,712			—			160,990
Net intercompany receivable		35,363		1,907,474			—			—			(1,942,837	)		—
Investment in subsidiaries		1,344,598		825,153			42,407			—			(2,212,158	)		—
Other assets		—		37,311			1,096			29,466			—			67,873

Total Assets	$	1,379,961	$	2,789,267		$	2,282,644		$	607,818		$	(4,154,995	)	$	2,904,695

Liabilities and Equity
Liabilities
Debt, net	$	—	$	1,407,733		$	—		$	13,948		$	—		$	1,421,681
Accounts payable and accrued expenses		35,753		36,887			20,500			1,150			—			94,290
Net intercompany payable		—		—			1,556,634			386,203			(1,942,837	)		—
Deferred revenue		—		232			17,866			6,016			—			24,114
Lease deposits and other obligations to tenants		—		(183	)		18,163			2,422			—			20,402

Total liabilities		35,753		1,444,669			1,613,163			409,739			(1,942,837	)		1,560,487
Total equity		1,344,208		1,344,598			669,481			198,079			(2,212,158	)		1,344,208

Total Liabilities and Equity	$	1,379,961	$	2,789,267		$	2,282,644		$	607,818		$	(4,154,995	)	$	2,904,695

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	29,189	$	5,650		$	(3,295	)	$	31,544
Straight-line rent		—			—			2,283		601			—			2,884
Income from direct financing leases		—			—			10,518		5,751			(4,971	)		11,298
Interest and fee income		—			5,004			9,096		7,317			(7,037	)		14,380

Total revenues		—			5,004			51,086		19,319			(15,303	)		60,106
Expenses
Real estate depreciation and amortization		—			—			8,012		702			—			8,714
Property-related		—			182			251		8,291			(8,266	)		458
General and administrative		—			6,867			—		(582	)		—			6,285
Acquisition expenses		—			4,179			—		—			—			4,179

Total operating expenses		—			11,228			8,263		8,411			(8,266	)		19,636

Operating income (loss)		—			(6,224	)		42,823		10,908			(7,037	)		40,470
Other income (expense)
Other income (expense)		—			5			—		(2	)		—			3
Earnings from equity and other interests		—			—			—		843			—			843
Interest income (expense)		—			(16,055	)		455		(7,267	)		7,037			(15,830	)
Income tax benefit (expense)		—			—			—		(94	)		—			(94	)

Net other income (expense)		—			(16,050	)		455		(6,520	)		7,037			(15,078	)

Income (loss) from continuing operations		—			(22,274	)		43,278		4,388			—			25,392
Income (loss) from discontinued operations		—			—			—		311			—			311
Equity in earnings of consolidated subsidiaries, net of income taxes		25,703			47,977			1,114		—			(74,794	)		—

Net income		25,703			25,703			44,392		4,699			(74,794	)		25,703
Net income (loss) attributable to non-controlling interests		(55	)		(55	)		—		—			55			(55	)

Net income attributable to MPT common stockholders	$	25,648		$	25,648		$	44,392	$	4,699		$	(74,739	)	$	25,648

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	86,789	$	16,328		$	(9,045	)	$	94,072
Straight-line rent		—			—			6,894		1,458			—			8,352
Income from direct financing leases		—			—			27,387		16,744			(14,847	)		29,284
Interest and fee income		—			15,112			27,363		21,872			(21,211	)		43,136

Total revenues		—			15,112			148,433		56,402			(45,103	)		174,844
Expenses
Real estate depreciation and amortization		—			—			23,720		2,107			—			25,827
Property-related		—			458			817		24,137			(23,892	)		1,520
General and administrative		—			21,286			—		(124	)		—			21,162
Acquisition expenses		—			6,457			—		—			—			6,457

Total operating expenses		—			28,201			24,537		26,120			(23,892	)		54,966

Operating income (loss)		—			(13,089	)		123,896		30,282			(21,211	)		119,878
Other income (expense)
Other income (expense)		—			(38	)		—		(207	)		—			(245	)
Earnings from equity and other interests		—			—			—		2,511			—			2,511
Interest income (expense)		—			(46,297	)		1,082		(21,892	)		21,211			(45,896	)
Income tax benefit (expense)		—			—			—		(261	)		—			(261	)

Net other income (expense)		—			(46,335	)		1,082		(19,849	)		21,211			(43,891	)

Income (loss) from continuing operations		—			(59,424	)		124,978		10,433			—			75,987
Income (loss) from discontinued operations		—			—			—		3,330			—			3,330
Equity in earnings of consolidated subsidiaries net of income taxes		79,317			138,741			3,355		—			(221,413	)		—

Net income		79,317			79,317			128,333		13,763			(221,413	)		79,317
Net income (loss) attributable to non-controlling interests		(165	)		(165	)		—		—			165			(165	)

Net income attributable to MPT common stockholders	$	79,152		$	79,152		$	128,333	$	13,763		$	(221,248	)	$	79,152

Condensed Consolidated Statements of Comprehensive Income

For the Three Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	25,703		$	25,703		$	44,392	$	4,699	$	(74,794	)	$	25,703
Other comprehensive income:
Unrealized gain on interest rate swap		182			182			—		—		(182	)		182

Total comprehensive income		25,885			25,885			44,392		4,699		(74,976	)		25,885
Comprehensive income attributable to non-controlling interests		(55	)		(55	)		—		—		55			(55	)

Comprehensive income attributable to MPT common stockholders	$	25,830		$	25,830		$	44,392	$	4,699	$	(74,921	)	$	25,830

Condensed Consolidated Statements of Comprehensive Income

For the Nine Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	79,317		$	79,317		$	128,333	$	13,763	$	(221,413	)	$	79,317
Other comprehensive income:
Unrealized gain on interest rate swap		2,788			2,788			—		—		(2,788	)		2,788

Total comprehensive income		82,105			82,105			128,333		13,763		(224,201	)		82,105
Comprehensive income attributable to non-controlling interests		(165	)		(165	)		—		—		165			(165	)

Comprehensive income attributable to MPT common stockholders	$	81,940		$	81,940		$	128,333	$	13,763	$	(224,036	)	$	81,940

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	91		$	(38,891	)	$	171,742		$	(31,378	)	$	—		$	101,564
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(356,250	)		(15,250	)		—			(371,500	)
Principal received on loans receivable		—			—			—			4,694			—			4,694
Net proceeds from sale of real estate		—			—			—			18,409			—			18,409
Investments in loans receivable		—			—			—			(1,445	)		—			(1,445	)
Construction in progress and other		—			(765	)		(63,690	)		1,033			—			(63,422	)

Net cash used in investing activities		—			(765	)		(419,940	)		7,441			—			(413,264	)
Financing Activities
Revolving credit facilities, net		—			(80,000	)		—			—			—			(80,000	)
Additions to term debt		—			153,000			—			—			—			153,000
Payments of term debt		—			(11,000	)		—			(185	)		—			(11,185	)
Distributions paid		(87,727	)		(87,928	)		—			—			87,727			(87,928	)
Proceeds from sale of common stock/units, net of offering costs		313,319			313,319			—			—			(313,319	)		313,319
Lease deposits and other obligations to tenants		—			—			1,699			1,890			—			3,589
Net payments relating to intercompany financing		(225,683	)		(267,545	)		244,934			22,702			225,592			—
Debt issuance costs paid and other financing activities		—			(4,282	)		—			—			—			(4,282	)

Net cash provided by (used in) financing activities		(91	)		15,564			246,633			24,407			—			286,513

Increase (decrease) in cash and cash equivalents for period		—			(24,092	)		(1,565	)		470			—			(25,187	)
Cash and cash equivalents at beginning of period		—			35,483			1,565			263			—			37,311

Cash and cash equivalents at end of period	$	—		$	11,391		$	—		$	733		$	—		$	12,124

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Unaudited Interim Condensed Consolidated Financial Statements

Reclassifications

Recent Accounting Developments

Variable Interest Entities

Variable Interest Entities


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	253,693	Mortgage and other loans	$	208,028
Equity investments	$	18,691	Other assets	$	5,293

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

- Definition

Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).

+ References + Details

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Carrying Value and Classification of Related Assets and Maximum Exposure to Loss

The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at September 30, 2014 (in thousands):


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	256,193	Mortgage and other loans	$	210,528
Equity investments	$	47,095	Other assets	$	5,293

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details

Real Estate and Lending Activities (Tables)

9 Months Ended

Sep. 30, 2014

Leases [Abstract]

Assets Acquired

As part of these acquisitions, we acquired the following assets during the first nine months:


	2014		2013
Assets Acquired
Land	$	13,058	$	16,220
Building		152,096		265,030
Intangible lease assets — subject to amortization (weighted average useful life 15 years)		12,828		—
Net investments in direct financing leases		—		85,000
Other loans		5,000		5,250

Total assets acquired	$	182,982	$	371,500

Summary of Status Update on Current Development Projects

See table below for a status update on our current development projects (in thousands):

Property

Location

Property Type

Operator

Commitment

Costs Incurred
as of
September 30,
2014

Estimated
Completion
Date

First Choice ER—Commerce City

Denver, CO

Acute Care Hospital

Adeptus Health

5,372

1,924

4Q 2014

UAB Medical West

Hoover, AL

Acute Care Hospital & Medical Office Building

Medical West, an affiliate of UAB

8,653

257

2Q 2015

First Choice ER—Summerwood

Houston, TX

Acute Care Hospital

Adeptus Health

6,015

1,535

2Q 2015

First Choice – Various

Various

Acute Care Hospital

Adeptus Health

143,985

—

Various

164,025

3,716

Components of Net Investment in Direct Financing Leases

The components of our net investment in DFLs consisted of the following (dollars in thousands):


	As of September 30, 2014			As of December 31, 2013
Minimum lease payments receivable	$	1,615,867		$	1,647,567
Estimated residual values		212,266			211,863
Less: Unearned income		(1,391,747	)		(1,428,406	)

Net investment in direct financing leases	$	436,386		$	431,024

Net Investment Under Monroe Facility

As of September 30, 2014 and December 31, 2013, our net investment (exclusive of the related real estate) in Monroe was as follows:


	As of September 30, 2014			As of December 31, 2013
Loans	$	35,443		$	31,341
Less: Loan impairment reserve		(32,943	)		(12,000	)

Loans, net		2,500			19,341
Interest, rent and other receivables		—			20,972

Net investment	$	2,500		$	40,313

Summary of Loans

The following is a summary of our loans (in thousands):


	As of September 30, 2014		As of December 31, 2013
Mortgage loans	$	385,093	$	388,756
Acquisition loans		108,028		109,655
Working capital and other loans		36,038		47,983
Convertible loan		3,352		3,352

	$	532,511	$	549,746

Debt (Tables)

9 Months Ended

Sep. 30, 2014

Debt Disclosure [Abstract]

Summary of Debt

The following is a summary of our debt (dollar amounts in thousands):


	As of September 30, 2014					As of December 31, 2013
	Balance		Interest Rate			Balance		Interest Rate
Revolving credit facility	$	—		Variable		$	105,000		Variable
2006 Senior Unsecured Notes		125,000		Various			125,000		Various
2011 Senior Unsecured Notes		450,000		6.875	%		450,000		6.875	%
2012 Senior Unsecured Notes:
Principal amount		350,000		6.375	%		350,000		6.375	%
Unamortized premium		2,610		—			2,873		—

		352,610					352,873
2013 Senior Unsecured Notes (A)		252,620		5.750	%		274,860		5.750	%
2014 Senior Unsecured Notes		300,000		5.500	%		—		—
Term loans		138,751		Various			113,948		Various

	$	1,618,981				$	1,421,681

(A)	These notes are Euro-denominated and reflect the exchange rates at September 30, 2014 and December 31, 2013, respectively.

Principal Payments Due for Debt

As of September 30, 2014, principal payments due for our debt (which exclude the effects of any premiums recorded) are as follows (in thousands):


2014	$	69
2015		283
2016		125,298
2017		320
2018		12,781
Thereafter		1,477,620

Total	$	1,616,371

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Summary of Fair Value Information of Financial Instruments

The following table summarizes fair value estimates for our financial instruments (in thousands):


	September 30, 2014						December 31, 2013
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	50,240		$	44,091		$	58,565		$	44,415
Loans (1)		335,061			350,770			351,713			358,383
Debt, net		(1,618,981	)		(1,698,142	)		(1,421,681	)		(1,486,090	)

(1)	Excludes loans related to Ernest since they are recorded at fair value and discussed below.

Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis

At September 30, 2014, these amounts were as follows (in thousands):


Asset Type	Fair Value		Cost		Asset Type Classification
Mortgage loans	$	100,000	$	100,000		Mortgage loans
Acquisition loans		97,450		97,450		Other loans
Equity investments		3,300		3,300		Other assets

	$	200,750	$	200,750

Summary Showing Sensitivity Analysis by Using Basis Point Variations

To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):


Basis Point Change in Marketability Discount	Estimated Increase (Decrease) In Fair Value
+100 basis points	$	(442	)
- 100 basis points		442

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2014

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations Including Revenue and Expenses of Previously Owned Facilities


	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2014		2013		2014			2013
Revenues	$	—	$	387	$	—		$	1,625
Gain on sale		—		—		—			2,054
Income		—		311		(2	)		3,330
Earnings per share/unit — diluted	$	—	$	—	$	—		$	0.02

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

Earnings Per Share/Common Unit (Tables)

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Calculation of Earnings Per Share

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (amounts in thousands):


	For the Three Months Ended September 30,
	2014			2013
Numerator:
Income from continuing operations	$	28,663		$	25,392
Non-controlling interests’ share in continuing operations		(126	)		(55	)
Participating securities’ share in earnings		(179	)		(166	)

Income from continuing operations, less participating securities’ share in earnings		28,358			25,171
Income from discontinued operations attributable to MPT common stockholders		—			311

Net income, less participating securities’ share in earnings	$	28,358		$	25,482

Denominator:
Basic weighted-average common shares		171,893			154,758
Dilutive potential common shares		746			1,211

Dilutive weighted-average common shares		172,639			155,969


	For the Nine Months Ended September 30,
	2014			2013
Numerator:
Income from continuing operations	$	35,769		$	75,987
Non-controlling interests’ share in continuing operations		(192	)		(165	)
Participating securities’ share in earnings		(584	)		(538	)

Income from continuing operations, less participating securities’ share in earnings		34,993			75,284
Income (loss) from discontinued operations attributable to MPT common stockholders		(2	)		3,330

Net income, less participating securities’ share in earnings	$	34,991		$	78,614

Denominator:
Basic weighted-average common shares		169,195			148,204
Dilutive potential common shares		657			1,313

Dilutive weighted-average common shares		169,852			149,517

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (amounts in thousands):


	For the Three Months Ended September 30,
	2014			2013
Numerator:
Income from continuing operations	$	28,663		$	25,392
Non-controlling interests’ share in continuing operations		(126	)		(55	)
Participating securities’ share in earnings		(179	)		(166	)

Income from continuing operations, less participating securities’ share in earnings		28,358			25,171
Income from discontinued operations attributable to MPT Operating Partnership partners		—			311

Net income, less participating securities’ share in earnings	$	28,358		$	25,482

Denominator:
Basic weighted-average units		171,893			154,758
Dilutive potential units		746			1,211

Dilutive weighted-average units		172,639			155,969


	For the Nine Months Ended September 30,
	2014			2013
Numerator:
Income from continuing operations	$	35,769		$	75,987
Non-controlling interests’ share in continuing operations		(192	)		(165	)
Participating securities’ share in earnings		(584	)		(538	)

Income from continuing operations, less participating securities’ share in earnings		34,993			75,284
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners		(2	)		3,330

Net income, less participating securities’ share in earnings	$	34,991		$	78,614

Denominator:
Basic weighted-average units		169,195			148,204
Dilutive potential units		657			1,313

Dilutive weighted-average units		169,852			149,517

Condensed Consolidating Financial Information (Tables)

9 Months Ended

Sep. 30, 2014

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheet

September 30, 2014

(in thousands)


	Parent		Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	—		$	1,995,236		$	65,947		$	—		$	2,061,183
Mortgage loans		—		—			285,093			100,000			—			385,093
Net investment in direct financing leases		—		—			214,709			221,677			—			436,386

Gross investment in real estate assets		—		—			2,495,038			387,624			—			2,882,662
Accumulated depreciation and amortization		—		—			(181,739	)		(9,543	)		—			(191,282	)
Net investment in real estate assets		—		—			2,313,299			378,081			—			2,691,380
Cash and cash equivalents		—		108,105			23,786			921			—			132,812
Interest and rent receivables		—		791			19,198			30,251			—			50,240
Straight-line rent receivables		—		—			44,633			11,770			—			56,403
Other loans		—		—			1,100			146,318			—			147,418
Net intercompany receivable		35,839		1,968,462			—			—			(2,004,301	)		—
Investment in subsidiaries		1,407,495		930,769			41,772			—			(2,380,036	)		—
Other assets		—		44,516			744			45,627			—			90,887

Total Assets	$	1,443,334	$	3,052,643		$	2,444,532		$	612,968		$	(4,384,337	)	$	3,169,140

Liabilities and Equity
Liabilities
Debt, net	$	—	$	1,605,230		$	—		$	13,751		$	—		$	1,618,981
Accounts payable and accrued expenses		36,229		40,235			8,265			697			—			85,426
Net intercompany payable		—		—			1,593,090			411,212			(2,004,302	)		—
Deferred revenue		—		214			24,432			6,184			—			30,830
Lease deposits and other obligations to tenants		—		(531	)		23,097			4,231			—			26,797

Total liabilities		36,229		1,645,148			1,648,884			436,075			(2,004,302	)		1,762,034
Total equity		1,407,105		1,407,495			795,648			176,893			(2,380,035	)		1,407,106

Total Liabilities and Equity	$	1,443,334	$	3,052,643		$	2,444,532		$	612,968		$	(4,384,337	)	$	3,169,140

Condensed Consolidated Balance Sheet

December 31, 2013

(in thousands)


	Parent		Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	—		$	1,796,415		$	69,040		$	—		$	1,865,455
Mortgage loans		—		—			285,106			103,650			—			388,756
Net investment in direct financing leases		—		—			212,543			218,481			—			431,024

Gross investment in real estate assets		—		—			2,294,064			391,171			—			2,685,235
Accumulated depreciation and amortization		—		—			(151,624	)		(8,152	)		—			(159,776	)

Net investment in real estate assets		—		—			2,142,440			383,019			—			2,525,459
Cash and cash equivalents		—		18,815			27,094			70			—			45,979
Interest and rent receivables		—		336			31,492			26,737			—			58,565
Straight-line rent receivables		—		—			37,015			8,814			—			45,829
Other loans		—		178			1,100			159,712			—			160,990
Net intercompany receivable		35,363		1,907,474			—			—			(1,942,837	)		—
Investment in subsidiaries		1,344,598		825,153			42,407			—			(2,212,158	)		—
Other assets		—		37,311			1,096			29,466			—			67,873

Total Assets	$	1,379,961	$	2,789,267		$	2,282,644		$	607,818		$	(4,154,995	)	$	2,904,695

Liabilities and Equity
Liabilities
Debt, net	$	—	$	1,407,733		$	—		$	13,948		$	—		$	1,421,681
Accounts payable and accrued expenses		35,753		36,887			20,500			1,150			—			94,290
Net intercompany payable		—		—			1,556,634			386,203			(1,942,837	)		—
Deferred revenue		—		232			17,866			6,016			—			24,114
Lease deposits and other obligations to tenants		—		(183	)		18,163			2,422			—			20,402

Total liabilities		35,753		1,444,669			1,613,163			409,739			(1,942,837	)		1,560,487
Total equity		1,344,208		1,344,598			669,481			198,079			(2,212,158	)		1,344,208

Total Liabilities and Equity	$	1,379,961	$	2,789,267		$	2,282,644		$	607,818		$	(4,154,995	)	$	2,904,695

Condensed Consolidated Statements of Income

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	69		$	45,703		$	6,424		$	(4,133	)	$	48,063
Straight-line rent		—			—			3,850			1,432			—			5,282
Income from direct financing leases		—			—			11,695			5,921			(5,308	)		12,308
Interest and fee income		—			9,323			14,336			7,338			(15,873	)		15,124

Total revenues		—			9,392			75,584			21,115			(25,314	)		80,777
Expenses
Real estate depreciation and amortization		—			—			12,814			540			—			13,354
Impairment charges		—			—			—			—			—			—
Property-related		—			169			732			9,171			(9,372	)		700
General and administrative		—			5,448			303			2,921			—			8,672
Acquisition expenses		—			469			1,929			2,488			—			4,886

Total operating expenses		—			6,086			15,778			15,120			(9,372	)		27,612

Operating income (expense)		—			3,306			59,806			5,995			(15,942	)		53,165
Other income (expense)
Other income (expense)		—			75			—			—			—			75
Earnings from equity and other interests		—			—			—			1,153			—			1,153
Interest income (expense)		—			(25,400	)		(8,304	)		(7,719	)		15,942			(25,481	)
Debt refinancing costs		—			—			—			—			—			—
Income tax benefit expense		—			—			(49	)		(200	)		—			(249	)

Net other income (expense)		—			(25,325	)		(8,353	)		(6,766	)		15,942			(24,502	)

Income (loss) from continuing operations		—			(22,019	)		51,453			(771	)		—			28,663
Income (loss) from discontinued operations		—			—			—			—			—			—
Equity in earnings of consolidated subsidiaries net of income taxes		28,663			50,682			995			—			(80,340	)		—

Net income		28,663			28,663			52,448			(771	)		(80,340	)		28,663
Net income (loss) attributable to non-controlling interests		(126	)		(126	)		—			—			126			(126	)

Net income attributable to MPT common stockholders	$	28,537		$	28,537		$	52,448		$	(771	)	$	(80,214	)	$	28,537

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	69		$	129,167		$	19,431		$	(11,715	)	$	136,952
Straight-line rent		—			—			7,881			2,767			—			10,648
Income from direct financing leases		—			—			34,956			17,691			(15,860	)		36,787
Interest and fee income		—			27,815			43,199			22,631			(47,606	)		46,039

Total revenues		—			27,884			215,203			62,520			(75,181	)		230,426
Expenses
Real estate depreciation and amortization		—			—			37,556			1,929			—			39,485
Impairment charges		—			289			19,002			30,837			—			50,128
Property-related		—			508			926			27,474			(27,507	)		1,401
General and administrative		—			22,096			560			3,180			—			25,836
Acquisition expenses		—			3,355			2,091			2,487			—			7,933

Total operating expenses		—			26,248			60,135			65,907			(27,507	)		124,783

Operating income (expense)		—			1,636			155,068			(3,387	)		(47,674	)		105,643
Other income (expense)
Other income (expense)		—			44			—			—			—			44
Earnings from equity and other interests		—			—			—			2,059			—			2,059
Interest income (expense)		—			(71,944	)		(24,836	)		(22,349	)		47,674			(71,455	)
Debt refinancing costs		—			(290	)		—			—			—			(290	)
Income tax benefit (expense)		—			—			(16	)		(216	)		—			(232	)

Net other income (expense)		—			(72,190	)		(24,852	)		(20,506	)		47,674			(69,874	)

Income (loss) from continuing operations		—			(70,554	)		130,216			(23,893	)		—			35,769
Income from discontinued operations		—			—			—			(2	)		—			(2	)
Equity in earnings of consolidated subsidiaries, net of income taxes		35,767			106,321			3,158			—			(145,246	)		—

Net income		35,767			35,767			133,374			(23,895	)		(145,246	)		35,767
Net income (loss) attributable to non-controlling interests		(192	)		(192	)		—			—			192			(192	)

Net income attributable to MPT common stockholders	$	35,575		$	35,575		$	133,374		$	(23,895	)	$	(145,054	)	$	35,575

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	29,189	$	5,650		$	(3,295	)	$	31,544
Straight-line rent		—			—			2,283		601			—			2,884
Income from direct financing leases		—			—			10,518		5,751			(4,971	)		11,298
Interest and fee income		—			5,004			9,096		7,317			(7,037	)		14,380

Total revenues		—			5,004			51,086		19,319			(15,303	)		60,106
Expenses
Real estate depreciation and amortization		—			—			8,012		702			—			8,714
Property-related		—			182			251		8,291			(8,266	)		458
General and administrative		—			6,867			—		(582	)		—			6,285
Acquisition expenses		—			4,179			—		—			—			4,179

Total operating expenses		—			11,228			8,263		8,411			(8,266	)		19,636

Operating income (loss)		—			(6,224	)		42,823		10,908			(7,037	)		40,470
Other income (expense)
Other income (expense)		—			5			—		(2	)		—			3
Earnings from equity and other interests		—			—			—		843			—			843
Interest income (expense)		—			(16,055	)		455		(7,267	)		7,037			(15,830	)
Income tax benefit (expense)		—			—			—		(94	)		—			(94	)

Net other income (expense)		—			(16,050	)		455		(6,520	)		7,037			(15,078	)

Income (loss) from continuing operations		—			(22,274	)		43,278		4,388			—			25,392
Income (loss) from discontinued operations		—			—			—		311			—			311
Equity in earnings of consolidated subsidiaries, net of income taxes		25,703			47,977			1,114		—			(74,794	)		—

Net income		25,703			25,703			44,392		4,699			(74,794	)		25,703
Net income (loss) attributable to non-controlling interests		(55	)		(55	)		—		—			55			(55	)

Net income attributable to MPT common stockholders	$	25,648		$	25,648		$	44,392	$	4,699		$	(74,739	)	$	25,648

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	86,789	$	16,328		$	(9,045	)	$	94,072
Straight-line rent		—			—			6,894		1,458			—			8,352
Income from direct financing leases		—			—			27,387		16,744			(14,847	)		29,284
Interest and fee income		—			15,112			27,363		21,872			(21,211	)		43,136

Total revenues		—			15,112			148,433		56,402			(45,103	)		174,844
Expenses
Real estate depreciation and amortization		—			—			23,720		2,107			—			25,827
Property-related		—			458			817		24,137			(23,892	)		1,520
General and administrative		—			21,286			—		(124	)		—			21,162
Acquisition expenses		—			6,457			—		—			—			6,457

Total operating expenses		—			28,201			24,537		26,120			(23,892	)		54,966

Operating income (loss)		—			(13,089	)		123,896		30,282			(21,211	)		119,878
Other income (expense)
Other income (expense)		—			(38	)		—		(207	)		—			(245	)
Earnings from equity and other interests		—			—			—		2,511			—			2,511
Interest income (expense)		—			(46,297	)		1,082		(21,892	)		21,211			(45,896	)
Income tax benefit (expense)		—			—			—		(261	)		—			(261	)

Net other income (expense)		—			(46,335	)		1,082		(19,849	)		21,211			(43,891	)

Income (loss) from continuing operations		—			(59,424	)		124,978		10,433			—			75,987
Income (loss) from discontinued operations		—			—			—		3,330			—			3,330
Equity in earnings of consolidated subsidiaries net of income taxes		79,317			138,741			3,355		—			(221,413	)		—

Net income		79,317			79,317			128,333		13,763			(221,413	)		79,317
Net income (loss) attributable to non-controlling interests		(165	)		(165	)		—		—			165			(165	)

Net income attributable to MPT common stockholders	$	79,152		$	79,152		$	128,333	$	13,763		$	(221,248	)	$	79,152

Condensed Consolidated Statements of Comprehensive Income

Condensed Consolidated Statements of Comprehensive Income

For the Three Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Net income (loss)	$	28,663		$	28,663		$	52,448	$	(771	)	$	(80,340	)	$	28,663
Other comprehensive income (loss):
Unrealized gain on interest rate swap		1,136			1,136			—		—			(1,136	)		1,136
Foreign currency translation gain (loss)		(1,319	)		(1,319	)		—		—			1,319			(1,319	)

Total comprehensive income		28,480			28,480			52,448		(771	)		(80,157	)		28,480
Comprehensive income attributable to non-controlling interests		(126	)		(126	)		—		—			126			(126	)

Comprehensive income attributable to MPT common stockholders	$	28,354		$	28,354		$	52,448	$	(771	)	$	(80,031	)	$	28,354

Condensed Consolidated Statements of Comprehensive Income

For the Nine Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Net income (loss)	$	35,767		$	35,767		$	133,374	$	(23,895	)	$	(145,246	)	$	35,767
Other comprehensive income (loss):
Unrealized gain on interest rate swap		2,342			2,342			—		—			(2,342	)		2,342
Foreign currency translation gain (loss)		(1,273	)		(1,273	)		—		—			1,273			(1,273	)

Total comprehensive income		36,836			36,836			133,374		(23,895	)		(146,315	)		36,836
Comprehensive income attributable to non-controlling interests		(192	)		(192	)		—		—			192			(192	)

Comprehensive income attributable to MPT common stockholders	$	36,644		$	36,644		$	133,374	$	(23,895	)	$	(146,123	)	$	36,644

Condensed Consolidated Statements of Comprehensive Income

For the Three Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	25,703		$	25,703		$	44,392	$	4,699	$	(74,794	)	$	25,703
Other comprehensive income:
Unrealized gain on interest rate swap		182			182			—		—		(182	)		182

Total comprehensive income		25,885			25,885			44,392		4,699		(74,976	)		25,885
Comprehensive income attributable to non-controlling interests		(55	)		(55	)		—		—		55			(55	)

Comprehensive income attributable to MPT common stockholders	$	25,830		$	25,830		$	44,392	$	4,699	$	(74,921	)	$	25,830

Condensed Consolidated Statements of Comprehensive Income

For the Nine Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	79,317		$	79,317		$	128,333	$	13,763	$	(221,413	)	$	79,317
Other comprehensive income:
Unrealized gain on interest rate swap		2,788			2,788			—		—		(2,788	)		2,788

Total comprehensive income		82,105			82,105			128,333		13,763		(224,201	)		82,105
Comprehensive income attributable to non-controlling interests		(165	)		(165	)		—		—		165			(165	)

Comprehensive income attributable to MPT common stockholders	$	81,940		$	81,940		$	128,333	$	13,763	$	(224,036	)	$	81,940

Condensed Consolidated Statements of Cash Flows

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2014

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(98	)	$	(76,425	)	$	221,310		$	(49,043	)	$	—		$	95,744
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(182,982	)		—			—			(182,982	)
Principal received on loans receivable		—			—			—			8,381			—			8,381
Net proceeds from sale of real estate		—			—			—			34,649			—			34,649
Investments in loans receivable		—			—			—			(9,102	)		—			(9,102	)
Construction in progress and other		—			(1,030	)		(95,489	)		(483	)		—			(97,002	)
Net cash provided by (used in) investing activities		—			(1,030	)		(278,471	)		33,445			—			(246,056	)
Financing Activities
Revolving credit facilities, net		—			(105,000	)		—			—			—			(105,000	)
Additions to term debt, net of discount		—			425,000			—			—			—			425,000
Payments of term debt		—			(100,176	)		—			(21	)		—			(100,197	)
Distributions paid		(107,842	)		(108,026	)		—			—			107,842			(108,026	)
Proceeds from sale of common shares/units, net of offering costs		128,270			128,270			—			—			(128,270	)		128,270
Lease deposits and other obligations to tenants		—			(360	)		9,431			1,808			—			10,879
Net payments relating to intercompany financing		(20,330	)		(61,206	)		46,446			14,662			20,428			—
Debt issuance costs paid and other financing activities		—			(11,757	)		—			—			—			(11,757	)

Net cash provided by financing activities		98			166,745			55,877			16,449			—			239,169

Increase (decrease) in cash and cash equivalents for period		—			89,290			(1,284	)		851			—			88,857
Effects of exchange rate changes on cash		—			—			(2,024	)		—			—			(2,024	)
Cash and cash equivalents at beginning of period		—			18,815			27,094			70			—			45,979

Cash and cash equivalents at end of period	$	—		$	108,105		$	23,786		$	921		$	—		$	132,812

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2013

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	91		$	(38,891	)	$	171,742		$	(31,378	)	$	—		$	101,564
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(356,250	)		(15,250	)		—			(371,500	)
Principal received on loans receivable		—			—			—			4,694			—			4,694
Net proceeds from sale of real estate		—			—			—			18,409			—			18,409
Investments in loans receivable		—			—			—			(1,445	)		—			(1,445	)
Construction in progress and other		—			(765	)		(63,690	)		1,033			—			(63,422	)

Net cash used in investing activities		—			(765	)		(419,940	)		(7,441	)		—			(413,264	)
Financing Activities
Revolving credit facilities, net		—			(80,000	)		—			—			—			(80,000	)
Additions to term debt		—			153,000			—			—			—			153,000
Payments of term debt		—			(11,000	)		—			(185	)		—			(11,185	)
Distributions paid		(87,727	)		(87,928	)		—			—			87,727			(87,928	)
Proceeds from sale of common stock/units, net of offering costs		313,319			313,319			—			—			(313,319	)		313,319
Lease deposits and other obligations to tenants		—			—			1,699			1,890			—			3,589
Net payments relating to intercompany financing		(225,683	)		(267,545	)		244,934			22,702			225,592			—
Debt issuance costs paid and other financing activities		—			(4,282	)		—			—			—			(4,282	)

Net cash provided by (used in) financing activities		(91	)		15,564			246,633			24,407			—			286,513

Increase (decrease) in cash and cash equivalents for period		—			(24,092	)		(1,565	)		470			—			(25,187	)
Cash and cash equivalents at beginning of period		—			35,483			1,565			263			—			37,311

Cash and cash equivalents at end of period	$	—		$	11,391		$	—		$	733		$	—		$	12,124

Summary of Significant Accounting Policies - Carrying Value and Classification of Related Assets and Maximum Exposure to Loss (Detail) $ in Thousands	Sep. 30, 2014 USD ($)
Loans, net [Member]
Variable Interest Entity [Line Items]
Maximum Loss Exposure	$ 256,193
Mortgage and other loans [Member]
Variable Interest Entity [Line Items]
Carrying Amount	210,528
Equity investments [Member]
Variable Interest Entity [Line Items]
Maximum Loss Exposure	47,095
Other assets [Member]
Variable Interest Entity [Line Items]
Carrying Amount	$ 5,293

Real Estate and Lending Activities - 2014 Activity - Additional Information (Detail) $ in Thousands, £ in Millions				3 Months Ended			9 Months Ended
	Sep. 19, 2014 USD ($) RenewalOptions	Jul. 01, 2014 USD ($)	Jul. 01, 2014 GBP (£)	Sep. 30, 2014 USD ($)	Mar. 31, 2014 USD ($)	Sep. 30, 2013 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2013 USD ($)	Jul. 01, 2014 GBP (£)
Significant Acquisitions and Disposals [Line Items]
Acquisition related expenses		$ 1,900	£ 1.1	$ 4,886		$ 4,179	$ 7,933	$ 6,457
2014 Activity [Member] \| Acute Care Hospital [Member]
Significant Acquisitions and Disposals [Line Items]
Acquisition costs					$ 115,000
Term of lease, years					15 years
Term of lease extension, years					3 years
2014 Activity [Member] \| Acute Care Hospital [Member] \| Fair value market [Member]
Significant Acquisitions and Disposals [Line Items]
Term of lease extension, years					12 years
2014 Activity [Member] \| Circle Health [Member]
Significant Acquisitions and Disposals [Line Items]
Acquired facility, carrying value of sale/leaseback transaction		$ 48,000							£ 28.3
Sale/leaseback transaction, initial term period		15 years	15 years
Sale/leaseback transaction, additional term period		15 years	15 years
Percentage change in annual retail price index, floor rate		2.00%							2.00%
Percentage change in annual retail price index, cap rate		5.00%							5.00%
2014 Activity [Member] \| Alecto Healthcare Services [Member] \| Acute Care Hospital [Member] \| Fairmont West Virginia [Member]
Significant Acquisitions and Disposals [Line Items]
Acquisition costs	$ 15,000
Term of lease, years	15 years
Term of lease extension, years	5 years
Number of lease extension options in current lease contract \| RenewalOptions	3
Working capital loan to the tenant	$ 5,000
Additional lease period	5 years
Additional fund committed to the tenant for capital improvements	$ 5,000

Real Estate and Lending Activities - 2013 Activity - Additional Information (Detail) - 2013 Activity [Member] $ in Millions			9 Months Ended
	Sep. 26, 2013 USD ($) RenewalOptions Facility	Jul. 11, 2013 USD ($) RenewalOptions Facility	Sep. 30, 2014 USD ($)	Jul. 18, 2013 USD ($)
Ernest [Member]
Significant Acquisitions and Disposals [Line Items]
Term of lease, years			20 years
Term Loan [Member] \| Ernest [Member]
Significant Acquisitions and Disposals [Line Items]
Loan on property			$ 5.3
Maximum [Member] \| Ernest [Member]
Significant Acquisitions and Disposals [Line Items]
Maximum rent increase percent			5.00%
Term of lease extension, years			5 years
Minimum [Member] \| Ernest [Member]
Significant Acquisitions and Disposals [Line Items]
Maximum rent increase percent			2.00%
Term of lease extension, years			3 years
Corpus Christi Rehabilitation Hospital [Member]
Significant Acquisitions and Disposals [Line Items]
Purchase price of acquisition				$ 10.5
Corpus Christi Rehabilitation Hospital [Member] \| Commitment [Member]
Significant Acquisitions and Disposals [Line Items]
Purchase price of acquisition				$ 0.5
Acute Care Hospital [Member] \| Kansas [Member]
Significant Acquisitions and Disposals [Line Items]
Number of facilities acquired \| Facility		2
Number of lease extension options in current lease contract \| RenewalOptions		2
Maximum rent increase percent		2.00%
Term of lease, years			10 years
Term of lease extension, years			5 years
Acquisition costs		$ 75.0
Acute Care Hospital [Member] \| Isasis Healthcare LLC [Member]
Significant Acquisitions and Disposals [Line Items]
Number of facilities acquired \| Facility	3
Purchase price of acquisition	$ 281.3
Initial leaseback term			15 years
Number of lease extension options in current lease contract \| RenewalOptions	2
Lease renewal option			5 years
Lease maturity year			2019
Extended lease maturity year			2028
Acute Care Hospital [Member] \| Isasis Healthcare LLC [Member] \| Maximum [Member]
Significant Acquisitions and Disposals [Line Items]
Maximum rent increase percent			2.50%

Real Estate and Lending Activities - Assets Acquired (Detail) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	$ 182,982		$ 371,500
Total assets acquired	436,386	$ 431,024
Net investments in direct financing leases [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired			85,000
Land [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	13,058		16,220
Building [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	152,096		265,030
Intangible lease assets - subject to amortization [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	12,828
Other loans [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	$ 5,000		$ 5,250

Real Estate and Lending Activities - Assets Acquired (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2014
Intangible lease assets - subject to amortization [Member]
Significant Acquisitions and Disposals [Line Items]
Weighted average useful life of acquired intangible lease assets (in years)	15 years

Real Estate and Lending Activities - Development Activities - Additional Information (Detail) $ in Thousands			9 Months Ended
	Aug. 15, 2014 USD ($) RenewalOptions	Jul. 29, 2014 USD ($)	Sep. 30, 2014 USD ($) RenewalOptions Facility
Significant Acquisitions and Disposals [Line Items]
Current development project			$ 164,025
Oakleaf Surgical Hospital [Member] \| Acute Care Hospital [Member] \| Altoona, WI [Member] \| National Surgical Hospitals [Member]
Significant Acquisitions and Disposals [Line Items]
Current development project			$ 30,500
Term of lease, years			15 years
Number of lease extension options in current lease contract \| RenewalOptions			2
Term of lease extension, years			5 years
Healthcare [Member]
Significant Acquisitions and Disposals [Line Items]
Term of lease, years	15 years
Number of lease extension options in current lease contract \| RenewalOptions	4
Term of lease extension, years	5 years
Agreement amount related to acquisition	$ 8,700
Development Activities [Member] \| Twelve Oaks Facility [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of facility partially occupied			55.00%
Lease agreement			15 years
Development Activities [Member] \| Northern Utah Rehabilitation Hospital [Member]
Significant Acquisitions and Disposals [Line Items]
Estimated total development cost			$ 19,000
Development Activities [Member] \| First Choice ER. [Member]
Significant Acquisitions and Disposals [Line Items]
Estimated total development cost			$ 73,700
Number of facilities leased \| Facility			16
Number of facilities under construction \| Facility			1
Development Activities [Member] \| First Choice ER. [Member] \| Minimum [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage increase in consumer price index		2.00%
Development Activities [Member] \| Adeptus Health [Member]
Significant Acquisitions and Disposals [Line Items]
Business acquisition, cost of acquired entity		$ 150,000
Sale/leaseback transaction, initial term period		15 years
Sale/leaseback transaction, additional term period		5 years

Real Estate and Lending Activities - Summary of Status Update on Current Development Projects (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2014 USD ($)
Business Acquisition [Line Items]
Original Commitment	$ 164,025
Costs Incurred as of September 30, 2014	3,716
First Choice ER - Commerce City [Member] \| Denver, CO [Member] \| Acute Care Hospital [Member] \| Adeptus Health [Member]
Business Acquisition [Line Items]
Original Commitment	5,372
Costs Incurred as of September 30, 2014	$ 1,924
Estimated Completion Date	4Q 2014
Medical West, an affiliate of UAB [Member] \| Hoover Al [Member] \| Acute Care Hospital And Medical Office Building [Member] \| Medical West, an Affiliate of UAB [Member]
Business Acquisition [Line Items]
Original Commitment	$ 8,653
Costs Incurred as of September 30, 2014	$ 257
Estimated Completion Date	2Q 2015
First Choice ER Summerwood [Member] \| Houston, TX [Member] \| Acute Care Hospital [Member] \| Adeptus Health [Member]
Business Acquisition [Line Items]
Original Commitment	$ 6,015
Costs Incurred as of September 30, 2014	$ 1,535
Estimated Completion Date	2Q 2015
First Choice Various [Member] \| Various [Member] \| Acute Care Hospital [Member] \| Adeptus Health [Member]
Business Acquisition [Line Items]
Original Commitment	$ 143,985
Estimated Completion Date	Various

Real Estate and Lending Activities - Disposals - Additional Information (Detail) $ in Thousands		1 Months Ended	9 Months Ended
	May 20, 2014 USD ($)	Apr. 30, 2013 USD ($) Hospital	Sep. 30, 2014 USD ($)	Sep. 30, 2013 USD ($)
Significant Acquisitions and Disposals [Line Items]
Proceeds from sale of real estate			$ 34,649	$ 18,409
Disposals [Member]
Significant Acquisitions and Disposals [Line Items]
Acquisition costs	$ 35,000
Real estate impairment charge	$ 3,100
Disposals [Member] \| Summit Hospital of Southeast Arizona and Summit Hospital of Southeast Texas [Member]
Significant Acquisitions and Disposals [Line Items]
Proceeds from sale of real estate		$ 18,500
Gain (loss) on sale of real estate		$ 2,100
Number of hospitals sold \| Hospital		2

Real Estate and Lending Activities - Leasing Operations - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2014 Leases
Ernest [Member]
Significant Acquisitions and Disposals [Line Items]
Number of direct financing leases	13
Prime Facilities [Member]
Significant Acquisitions and Disposals [Line Items]
Number of direct financing leases	5

Real Estate and Lending Activities - Components of Net Investment in Direct Financing Leases (Detail) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Business Combinations [Abstract]
Minimum lease payments receivable	$ 1,615,867	$ 1,647,567
Estimated residual values	212,266	211,863
Less: Unearned income	(1,391,747)	(1,428,406)
Net investment in direct financing leases	$ 436,386	$ 431,024

Real Estate and Lending Activities - Net Investment Under Monroe Facility (Detail) - Monroe Facility [Member] - USD ($)	Sep. 30, 2014	Dec. 31, 2013
Investments In Loans [Line Items]
Loans	$ 35,443	$ 31,341
Less: Loan impairment reserve	(32,943)	(12,000)
Loans, net	2,500	19,341
Interest, rent and other receivables		20,972
Net investment	$ 2,500	$ 40,313

Real Estate and Lending Activities - Monroe Facility - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended		9 Months Ended	12 Months Ended
	Oct. 31, 2014	Jul. 31, 2014	Jun. 30, 2014	Mar. 31, 2014	Sep. 30, 2014	Dec. 31, 2010
Significant Acquisitions and Disposals [Line Items]
Impairment charges					$ 50,128
Monroe Facility [Member]
Significant Acquisitions and Disposals [Line Items]
Impairment of working capital loan recognized						$ 12,000
Impairment charges			$ 26,500	$ 20,500
Cash rents		$ 2,100
Amount of bankruptcy claims settled					5,000
Amount paid in settlement of bankruptcy claims					2,500
Net investment					$ 27,500
Monroe Facility [Member] \| Subsequent Event [Member]
Significant Acquisitions and Disposals [Line Items]
Amount paid in settlement of bankruptcy claims	$ 1,000

Real Estate and Lending Activities - Florence Facility - Additional Information (Detail) - Florence acute care facility [Member] $ in Millions	Sep. 30, 2014 USD ($)
Significant Acquisitions and Disposals [Line Items]
Real estate investment	$ 27.6
Outstanding rent receivables	1.0
Letter of Credit [Member]
Significant Acquisitions and Disposals [Line Items]
Letter of credit outstanding	$ 1.2

Real Estate and Lending Activities - Gilbert Facility - Additional Information (Detail) - Gilbert facility [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2014	Sep. 30, 2014
Significant Acquisitions and Disposals [Line Items]
Amortization of the related lease intangible asset	$ 1.0
Outstanding rent receivables		$ 0.1
Straight line rent receivables write-off	$ 1.1
Real estate investment		$ 14.2

Real Estate and Lending Activities - Summary of Loans (Detail) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Loans [Line Items]
Loans Receivable Net	$ 532,511	$ 549,746
Mortgage loans [Member]
Loans [Line Items]
Loans Receivable Net	385,093	388,756
Acquisition loans [Member]
Loans [Line Items]
Loans Receivable Net	108,028	109,655
Working capital and other loans [Member]
Loans [Line Items]
Loans Receivable Net	36,038	47,983
Convertible loan [Member]
Loans [Line Items]
Loans Receivable Net	$ 3,352	$ 3,352

Real Estate and Lending Activities - Loans - Additional Information (Detail) - USD ($) $ in Millions		9 Months Ended
	Mar. 01, 2012	Sep. 30, 2014
Business Combinations [Abstract]
Amount of convertible note converted into equity interest	$ 1.7
Convertible note	$ 5.0
Percentage of equity shares from convertible debt	9.90%	15.10%
Remaining convertible debt after conversion of part of debt		$ 3.3

Real Estate and Lending Activities - Concentrations of Credit Risk - Additional Information (Detail) - Concentration of Credit Risks [Member] - Investment	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Significant Acquisitions and Disposals [Line Items]
Number of investment in property	0		0
Maximum percentage of entity's total assets invested on single property	4.00%		4.00%
California [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of total assets accounted			17.20%		18.70%
Texas [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of total assets accounted			22.50%		22.70%
European [Member] \| Minimum [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of total assets accounted			9.00%
Ernest [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	26.40%	33.90%	27.80%	32.60%
Percentage of total assets accounted	22.50%				24.50%
Prime Health Care Services [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	18.30%	20.80%	18.70%	20.60%
Percentage of total assets accounted	15.30%				15.90%

Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
Debt - Summary of Debt (Detail) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Principal amount	$ 1,616,371
Debt	$ 1,618,981	$ 1,421,681
2011 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	6.875%	6.875%
Debt	$ 450,000	$ 450,000
Revolving credit facility [Member]
Debt Instrument [Line Items]
Interest rate	Variable	Variable
Debt		$ 105,000
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Interest rate	Various	Various
Debt	$ 125,000	$ 125,000
2012 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	6.375%	6.375%
Principal amount	$ 350,000	$ 350,000
Unamortized premium	2,610	2,873
Debt	$ 352,610	$ 352,873
2013 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	5.75%	5.75%
Debt	$ 252,620	$ 274,860
2014 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	5.50%
Debt	$ 300,000
Term Loan [Member]
Debt Instrument [Line Items]
Interest rate	Various	Various
Debt	$ 138,751	$ 113,948

Debt - Principal Payments Due for Debt (Detail) $ in Thousands	Sep. 30, 2014 USD ($)
Debt Disclosure [Abstract]
2014	$ 69
2015	283
2016	125,298
2017	320
2018	12,781
Thereafter	1,477,620
Total	$ 1,616,371

Debt - Credit Facility - Additional Information (Detail) € in Millions		3 Months Ended	9 Months Ended
	Jun. 19, 2014 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2014 USD ($)	Oct. 17, 2014 USD ($)	Oct. 17, 2014 EUR (€)
Subsequent Event [Member]
Debt Instrument [Line Items]
Accordion to existing credit facility				$ 250,000,000
Aggregate commited size of credit facility				1,150,000,000	€ 500
Subsequent Event [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Accordion to existing credit facility				400,000,000
Aggregate commited size of credit facility				1,550,000,000
Credit Facility [Member]
Debt Instrument [Line Items]
Amount of senior unsecured credit facility paid off	$ 900,000,000
Credit Facility [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Accordion to existing credit facility				250,000,000
Aggregate commited size of credit facility				1,150,000,000	€ 500
Credit Facility [Member] \| Subsequent Event [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Accordion to existing credit facility				400,000,000
Aggregate commited size of credit facility				$ 1,550,000,000
Credit Facility [Member] \| Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Amount of senior unsecured debt	775,000,000
Refinancing charge		$ 300,000
Aggregate commited size of credit facility		$ 0.00	$ 0.00
Credit Facility [Member] \| Unsecured Revolving Credit Facility [Member] \| Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			0.50%
Credit Facility [Member] \| Unsecured Revolving Credit Facility [Member] \| Euro Dollar Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.00%
Credit Facility [Member] \| Unsecured Revolving Credit Facility [Member] \| London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			2.00%
Credit Facility [Member] \| Unsecured Revolving Credit Facility [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding	400,000,000
Debt instrument, basis spread of interest rate			0.70%
Credit facilities, percentage of commitment fee on unused capacity			0.25%
Credit Facility [Member] \| Unsecured Revolving Credit Facility [Member] \| Minimum [Member] \| London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.70%
Credit Facility [Member] \| Unsecured Revolving Credit Facility [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding	100,000,000
Debt instrument, basis spread of interest rate			1.25%
Credit facilities, percentage of commitment fee on unused capacity			0.35%
Credit Facility [Member] \| Unsecured Revolving Credit Facility [Member] \| Maximum [Member] \| London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			2.25%
Credit Facility [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Amount of senior unsecured credit facility paid off	250,000,000
Amount of senior unsecured debt	$ 125,000,000
Effective interest rate		2.11%	2.11%
Credit Facility [Member] \| Term Loan [Member] \| Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			0.50%
Credit Facility [Member] \| Term Loan [Member] \| Euro Dollar Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.00%
Credit Facility [Member] \| Term Loan [Member] \| London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.95%
Credit Facility [Member] \| Term Loan [Member] \| Initial Spread [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			0.95%
Credit Facility [Member] \| Term Loan [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			0.60%
Credit Facility [Member] \| Term Loan [Member] \| Minimum [Member] \| London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.60%
Credit Facility [Member] \| Term Loan [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			1.20%
Credit Facility [Member] \| Term Loan [Member] \| Maximum [Member] \| London Interbank Offered Rate [Member]
Debt Instrument [Line Items]
Debt instrument, basis spread of interest rate			2.20%

Debt - 2014 Senior Unsecured Notes - Additional Information (Detail) - 2014 Senior Unsecured Notes [Member] - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2014	Apr. 17, 2014
Debt Instrument [Line Items]
Senior unsecured notes, value of offering		$ 300
Senior unsecured notes, interest rate	5.50%
Senior unsecured notes, redemption percentage on principal amount	35.00%
Senior unsecured notes, repurchase price percentage on principal amount plus accrued and unpaid interest	101.00%

Debt - Interest Rate Swap - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Oct. 31, 2011	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Interest Rate Contract [Member]
Debt Instrument [Line Items]
Fair value of the interest rate swaps		$ 6.7		$ 6.7		$ 9.0
Interest Rate Contract One [Member]
Debt Instrument [Line Items]
Interest rate of interest rate derivative instrument		5.507%		5.507%
Maturity date of interest rate swap		July 2016
Interest Rate Contract Two [Member]
Debt Instrument [Line Items]
Maturity date of interest rate swap		October 2016
Interest rate swap, amount fixed	$ 60.0
Interest rate of derivative instrument	5.675%
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Hedge ineffectiveness and income statement effect in period		$ 0.0	$ 0.0	$ 0.0	$ 0.0
Other assets, collateral		3.5		$ 3.5		$ 5.0
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Portion of debt instrument face amount		$ 65.0

Debt - Covenants - Additional Information (Detail)	9 Months Ended
Debt - Covenants - Additional Information (Detail)	Sep. 30, 2014
Debt Disclosure [Abstract]
Percentage of dividends which could be paid from adjusted operating funds	95.00%
Percentage of dividends which could be paid from operation funds	95.00%
Maximum percentage of total unencumbered assets	150.00%

Common Stock/Partner's Capital - Additional Information (Detail) $ / shares in Units, shares in Thousands, $ in Thousands				1 Months Ended	9 Months Ended
	Mar. 11, 2014 USD ($) shares	Aug. 20, 2013 USD ($) $ / shares shares	Feb. 28, 2013 USD ($) $ / shares shares	Jan. 31, 2014 USD ($)	Sep. 30, 2014 USD ($) Director Employee Partner $ / shares shares	Sep. 30, 2013 USD ($) shares	Dec. 31, 2013 shares
Class of Stock [Line Items]
Common stock, shares issued \| shares					171,626		161,310
Net proceed from issuance of common stock					$ 128,270	$ 313,319
MPT Operating Partnership, L.P. [Member]
Class of Stock [Line Items]
Net proceed from issuance of common stock					$ 128,270	$ 313,319
Ownership interest in equity					99.90%
Number of units sold \| shares					9,800	24,200
Number of other partners \| Partner					3
Employee [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage \| Employee					2
Director [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage \| Director					1
Public Offering [Member]
Class of Stock [Line Items]
Common stock, shares issued \| shares	7,700	11,500	12,700
Net proceed from issuance of common stock	$ 100,200	$ 140,400	$ 172,900
Additional shares purchased by underwriters \| shares	1,200	1,500	1,700
Time granted to underwriters to purchase shares					30 days
Net proceeds from additional issuance of shares	$ 16,000
Share price \| $ / shares		$ 12.75	$ 14.25
Market Equity Offering Program [Member]
Class of Stock [Line Items]
Common stock, shares issued \| shares					900
Net proceed from issuance of common stock					$ 12,300
Sales commission percentage				1.25%
Market Equity Offering Program [Member] \| IPO [Member]
Class of Stock [Line Items]
Public offering price for common stock per share \| $ / shares					$ 13.21
Market Equity Offering Program [Member] \| Maximum [Member]
Class of Stock [Line Items]
Number of shares can be sold out				$ 250,000

Stock Awards - Additional Information (Detail) - shares	9 Months Ended
Stock Awards - Additional Information (Detail) - shares	Sep. 30, 2014	Sep. 30, 2013
Time-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share - based compensation ,shares issued	345,984	258,736
Stock awards vesting period in years	3 years
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share - based compensation ,shares issued	324,754	222,566
Stock awards vesting period in years	3 years
Multi-year performance-based awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share - based compensation ,shares issued	500,000	550,000
Stock awards vesting period in years	3 years
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	7,643,651
Common stock remaining for future stock awards transferred to the equity incentive plan	6,436,291

Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Fair Value Disclosures [Abstract]
Interest and rent receivables, Book value	$ 50,240	$ 58,565
Loans, Book value	335,061	351,713
Debt, net Book value	(1,618,981)	(1,421,681)
Interest and rent receivables, Fair value	44,091	44,415
Loans, Fair value	350,770	358,383
Debt, net Fair value	$ (1,698,142)	$ (1,486,090)

Fair Value of Financial Instruments - Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis (Detail) $ in Thousands	Sep. 30, 2014 USD ($)
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	$ 200,750
Cost	200,750
Fair Value Measurements, Recurring [Member] \| Acquisition loans [Member] \| Other loans [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	97,450
Cost	97,450
Fair Value Measurements, Recurring [Member] \| Equity investments [Member] \| Other assets [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	3,300
Cost	3,300
Fair Value Measurements, Recurring [Member] \| Mortgage loans [Member] \| Mortgage loans [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	100,000
Cost	$ 100,000

Fair Value of Financial Instruments - Additional information (Detail)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]
Adjustment for marketability discount	40.00%

Fair Value of Financial Instruments - Summary Showing Sensitivity Analysis by Using Basis Point Variations (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2014 USD ($)
+100 basis points [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$ (442)
- 100 basis points [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$ 442

Discontinued Operations - Discontinued Operations Include Revenue and Expenses of Previously Owned Facilities (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Discontinued Operations and Disposal Groups [Abstract]
Revenues		$ 387		$ 1,625
Gain on sale				2,054
Income		$ 311	$ (2)	$ 3,330
Earnings per share/unit - diluted				$ 0.02

Earnings Per Share/Common Unit - Calculation of Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 28,663	$ 25,392	$ 35,769	$ 75,987
Non-controlling interests' share in continuing operations	(126)	(55)	(192)	(165)
Participating securities' share in earnings	(179)	(166)	(584)	(538)
Income from continuing operations, less participating securities' share in earnings	28,358	25,171	34,993	75,284
Income (loss) from discontinued operations attributable to MPT common stockholders		311	(2)	3,330
Net income, less participating securities' share in earnings	$ 28,358	$ 25,482	$ 34,991	$ 78,614
Basic weighted-average common shares	171,893	154,758	169,195	148,204
Dilutive potential common shares	746	1,211	657	1,313
Dilutive weighted-average common shares	172,639	155,969	169,852	149,517
MPT Operating Partnership, L.P. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 28,663	$ 25,392	$ 35,769	$ 75,987
Non-controlling interests' share in continuing operations	(126)	(55)	(192)	(165)
Participating securities' share in earnings	(179)	(166)	(584)	(538)
Income from continuing operations, less participating securities' share in earnings	28,358	25,171	34,993	75,284
Income (loss) from discontinued operations attributable to MPT common stockholders		311	(2)	3,330
Net income, less participating securities' share in earnings	$ 28,358	$ 25,482	$ 34,991	$ 78,614
Basic weighted-average common shares	171,893	154,758	169,195	148,204
Dilutive potential common shares	746	1,211	657	1,313
Dilutive weighted-average common shares	172,639	155,969	169,852	149,517

Subsequent Events - Additional Information (Detail) $ / shares in Units, shares in Thousands, $ in Thousands, € in Millions								9 Months Ended
	Nov. 30, 2014 USD ($) $ / shares shares	Oct. 31, 2014 USD ($) Bed	Oct. 25, 2014	Oct. 15, 2014 USD ($) Hospital	Oct. 15, 2014 EUR (€) Hospital	Sep. 18, 2014 USD ($) Bed Hospital	Sep. 18, 2014 EUR (€) Bed Hospital	Sep. 30, 2014 USD ($) $ / shares shares	Sep. 30, 2013 USD ($)	Oct. 17, 2014 USD ($)	Oct. 17, 2014 EUR (€)	Dec. 31, 2013 shares
Subsequent Event [Line Items]
Period for extended lease								Three five-year
Common stock, shares issued \| shares								171,626				161,310
Net proceed from issuance of common stock								$ 128,270	$ 313,319
RHM Rehabilitation Facilities [Member]
Subsequent Event [Line Items]
Aggregate purchase price						$ 81,000	€ 63.6
Number of rehabilitation hospitals \| Hospital						3	3
RHM Rehabilitation Facilities [Member] \| Bad Liebenstein [Member]
Subsequent Event [Line Items]
Number of beds \| Bed						211	211
RHM Rehabilitation Facilities [Member] \| Bad Tolz [Member]
Subsequent Event [Line Items]
Number of beds \| Bed						248	248
RHM Rehabilitation Facilities [Member] \| Bad Mergentheim [Member]
Subsequent Event [Line Items]
Number of beds \| Bed						271	271
Subsequent Event [Member]
Subsequent Event [Line Items]
Aggregate purchase price		$ 32,500
Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage				5.10%	5.10%
Lease term		15 years	27 years
Accordion to existing credit facility										$ 250,000
Aggregate commited size of credit facility										1,150,000	€ 500.0
Number of beds \| Bed		237
Working capital loan		$ 3,000
Subsequent Event [Member] \| Minimum [Member]
Subsequent Event [Line Items]
Effective annual rent escalation, percentage			1.00%
Subsequent Event [Member] \| Maximum [Member]
Subsequent Event [Line Items]
Effective annual rent escalation, percentage			70.00%
Accordion to existing credit facility										400,000
Aggregate commited size of credit facility										1,550,000
One-year senior unsecured term loan										$ 225,000
Working capital loan		$ 7,500
Subsequent Event [Member] \| Median [Member]
Subsequent Event [Line Items]
Aggregate purchase price				$ 900,000	€ 705.0
Number of rehabilitation hospitals \| Hospital				38	38
Number of acute care hospitals \| Hospital				2	2
Subsequent Event [Member] \| Waterland [Member]
Subsequent Event [Line Items]
Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage				94.90%	94.90%
Market Equity Offering Program [Member]
Subsequent Event [Line Items]
Common stock, shares issued \| shares								900
Net proceed from issuance of common stock								$ 12,300
Market Equity Offering Program [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock, shares issued \| shares	800
Net proceed from issuance of common stock	$ 10,300
Market Equity Offering Program [Member] \| IPO [Member]
Subsequent Event [Line Items]
Public offering price for common stock per share \| $ / shares								$ 13.21
Market Equity Offering Program [Member] \| IPO [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Public offering price for common stock per share \| $ / shares	$ 13.62

Condensed Consolidating Financial Information - Condensed Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements and intangible lease assets	$ 2,061,183	$ 1,865,455
Mortgage loans	385,093	388,756
Investment in direct financing leases	436,386	431,024
Gross investment in real estate assets	2,882,662	2,685,235
Accumulated depreciation and amortization	(191,282)	(159,776)
Net investment in real estate assets	2,691,380	2,525,459
Cash and cash equivalents	132,812	45,979	$ 12,124	$ 37,311
Interest and rent receivables	50,240	58,565
Straight-line rent receivables	56,403	45,829
Other loans	147,418	160,990
Other assets	90,887	67,873
Total Assets	3,169,140	2,904,695
Debt, net	1,618,981	1,421,681
Accounts payable and accrued expenses	85,426	94,290
Deferred revenue	30,830	24,114
Lease deposits and other obligations to tenants	26,797	20,402
Total liabilities	1,762,034	1,560,487
Total equity	1,407,106	1,344,208
Total Liabilities and Equity	3,169,140	2,904,695
Eliminations [Member]
Condensed Financial Statements, Captions [Line Items]
Net intercompany receivable	(2,004,301)	(1,942,837)
Investment in subsidiaries	(2,380,036)	(2,212,158)
Total Assets	(4,384,337)	(4,154,995)
Net intercompany payable	(2,004,302)	(1,942,837)
Total liabilities	(2,004,302)	(1,942,837)
Total equity	(2,380,035)	(2,212,158)
Total Liabilities and Equity	(4,384,337)	(4,154,995)
Parent [Member]
Condensed Financial Statements, Captions [Line Items]
Net intercompany receivable	35,839	35,363
Investment in subsidiaries	1,407,495	1,344,598
Total Assets	1,443,334	1,379,961
Accounts payable and accrued expenses	36,229	35,753
Total liabilities	36,229	35,753
Total equity	1,407,105	1,344,208
Total Liabilities and Equity	1,443,334	1,379,961
Subsidiary Issuers [Member]
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	108,105	18,815	11,391	35,483
Interest and rent receivables	791	336
Other loans		178
Net intercompany receivable	1,968,462	1,907,474
Investment in subsidiaries	930,769	825,153
Other assets	44,516	37,311
Total Assets	3,052,643	2,789,267
Debt, net	1,605,230	1,407,733
Accounts payable and accrued expenses	40,235	36,887
Deferred revenue	214	232
Lease deposits and other obligations to tenants	(531)	(183)
Total liabilities	1,645,148	1,444,669
Total equity	1,407,495	1,344,598
Total Liabilities and Equity	3,052,643	2,789,267
Subsidiary Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements and intangible lease assets	1,995,236	1,796,415
Mortgage loans	285,093	285,106
Investment in direct financing leases	214,709	212,543
Gross investment in real estate assets	2,495,038	2,294,064
Accumulated depreciation and amortization	(181,739)	(151,624)
Net investment in real estate assets	2,313,299	2,142,440
Cash and cash equivalents	23,786	27,094		1,565
Interest and rent receivables	19,198	31,492
Straight-line rent receivables	44,633	37,015
Other loans	1,100	1,100
Investment in subsidiaries	41,772	42,407
Other assets	744	1,096
Total Assets	2,444,532	2,282,644
Accounts payable and accrued expenses	8,265	20,500
Net intercompany payable	1,593,090	1,556,634
Deferred revenue	24,432	17,866
Lease deposits and other obligations to tenants	23,097	18,163
Total liabilities	1,648,884	1,613,163
Total equity	795,648	669,481
Total Liabilities and Equity	2,444,532	2,282,644
Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements and intangible lease assets	65,947	69,040
Mortgage loans	100,000	103,650
Investment in direct financing leases	221,677	218,481
Gross investment in real estate assets	387,624	391,171
Accumulated depreciation and amortization	(9,543)	(8,152)
Net investment in real estate assets	378,081	383,019
Cash and cash equivalents	921	70	$ 733	$ 263
Interest and rent receivables	30,251	26,737
Straight-line rent receivables	11,770	8,814
Other loans	146,318	159,712
Other assets	45,627	29,466
Total Assets	612,968	607,818
Debt, net	13,751	13,948
Accounts payable and accrued expenses	697	1,150
Net intercompany payable	411,212	386,203
Deferred revenue	6,184	6,016
Lease deposits and other obligations to tenants	4,231	2,422
Total liabilities	436,075	409,739
Total equity	176,893	198,079
Total Liabilities and Equity	$ 612,968	$ 607,818

Condensed Consolidating Financial Information - Condensed Consolidated Statements of Income (Detail) $ in Thousands, £ in Millions			3 Months Ended		9 Months Ended
	Jul. 01, 2014 USD ($)	Jul. 01, 2014 GBP (£)	Sep. 30, 2014 USD ($)	Sep. 30, 2013 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2013 USD ($)
Revenues
Rent billed			$ 48,063	$ 31,544	$ 136,952	$ 94,072
Straight-line rent			5,282	2,884	10,648	8,352
Income from direct financing leases			12,308	11,298	36,787	29,284
Interest and fee income			15,124	14,380	46,039	43,136
Total revenues			80,777	60,106	230,426	174,844
Expenses
Real estate depreciation and amortization			13,354	8,714	39,485	25,827
Impairment charges					50,128
Property-related			700	458	1,401	1,520
General and administrative			8,672	6,285	25,836	21,162
Acquisition expenses	$ 1,900	£ 1.1	4,886	4,179	7,933	6,457
Total operating expenses			27,612	19,636	124,783	54,966
Operating income (expense)			53,165	40,470	105,643	119,878
Other income (expense)
Other income (expense)			75	3	44	(245)
Earnings from equity and other interests			1,153	843	2,059	2,511
Interest income (expense)			(25,481)	(15,830)	(71,455)	(45,896)
Debt refinancing costs					(290)
Income tax benefit (expense)			(249)	(94)	(232)	(261)
Net other income (expense)			(24,502)	(15,078)	(69,874)	(43,891)
Income (loss) from continuing operations			28,663	25,392	35,769	75,987
Income (loss) from discontinued operations				311	(2)	3,330
Net income			28,663	25,703	35,767	79,317
Income (loss) from continuing operations			28,663	25,392	35,769	75,987
Income (loss) from discontinued operations				311	(2)	3,330
Net income			28,663	25,703	35,767	79,317
Net income (loss) attributable to non-controlling interests			(126)	(55)	(192)	(165)
Net income attributable to MPT common stockholders			28,537	25,648	35,575	79,152
Eliminations [Member]
Revenues
Rent billed			(4,133)	(3,295)	(11,715)	(9,045)
Income from direct financing leases			(5,308)	(4,971)	(15,860)	(14,847)
Interest and fee income			(15,873)	(7,037)	(47,606)	(21,211)
Total revenues			(25,314)	(15,303)	(75,181)	(45,103)
Expenses
Property-related			(9,372)	(8,266)	(27,507)	(23,892)
Total operating expenses			(9,372)	(8,266)	(27,507)	(23,892)
Operating income (expense)			(15,942)	(7,037)	(47,674)	(21,211)
Other income (expense)
Interest income (expense)			15,942	7,037	47,674	21,211
Net other income (expense)			15,942	7,037	47,674	21,211
Equity in earnings of consolidated subsidiaries net of income taxes			(80,340)	(74,794)	(145,246)	(221,413)
Net income			(80,340)	(74,794)	(145,246)	(221,413)
Equity in earnings of consolidated subsidiaries net of income taxes			(80,340)	(74,794)	(145,246)	(221,413)
Net income			(80,340)	(74,794)	(145,246)	(221,413)
Net income (loss) attributable to non-controlling interests			126	55	192	165
Net income attributable to MPT common stockholders			(80,214)	(74,739)	(145,054)	(221,248)
Parent [Member]
Other income (expense)
Equity in earnings of consolidated subsidiaries net of income taxes			28,663	25,703	35,767	79,317
Net income			28,663	25,703	35,767	79,317
Equity in earnings of consolidated subsidiaries net of income taxes			28,663	25,703	35,767	79,317
Net income			28,663	25,703	35,767	79,317
Net income (loss) attributable to non-controlling interests			(126)	(55)	(192)	(165)
Net income attributable to MPT common stockholders			28,537	25,648	35,575	79,152
Subsidiary Issuers [Member]
Revenues
Rent billed			69		69
Interest and fee income			9,323	5,004	27,815	15,112
Total revenues			9,392	5,004	27,884	15,112
Expenses
Impairment charges					289
Property-related			169	182	508	458
General and administrative			5,448	6,867	22,096	21,286
Acquisition expenses			469	4,179	3,355	6,457
Total operating expenses			6,086	11,228	26,248	28,201
Operating income (expense)			3,306	(6,224)	1,636	(13,089)
Other income (expense)
Other income (expense)			75	5	44	(38)
Interest income (expense)			(25,400)	(16,055)	(71,944)	(46,297)
Debt refinancing costs					(290)
Net other income (expense)			(25,325)	(16,050)	(72,190)	(46,335)
Income (loss) from continuing operations			(22,019)	(22,274)	(70,554)	(59,424)
Equity in earnings of consolidated subsidiaries net of income taxes			50,682	47,977	106,321	138,741
Net income			28,663	25,703	35,767	79,317
Income (loss) from continuing operations			(22,019)	(22,274)	(70,554)	(59,424)
Equity in earnings of consolidated subsidiaries net of income taxes			50,682	47,977	106,321	138,741
Net income			28,663	25,703	35,767	79,317
Net income (loss) attributable to non-controlling interests			(126)	(55)	(192)	(165)
Net income attributable to MPT common stockholders			28,537	25,648	35,575	79,152
Subsidiary Guarantors [Member]
Revenues
Rent billed			45,703	29,189	129,167	86,789
Straight-line rent			3,850	2,283	7,881	6,894
Income from direct financing leases			11,695	10,518	34,956	27,387
Interest and fee income			14,336	9,096	43,199	27,363
Total revenues			75,584	51,086	215,203	148,433
Expenses
Real estate depreciation and amortization			12,814	8,012	37,556	23,720
Impairment charges					19,002
Property-related			732	251	926	817
General and administrative			303		560
Acquisition expenses			1,929		2,091
Total operating expenses			15,778	8,263	60,135	24,537
Operating income (expense)			59,806	42,823	155,068	123,896
Other income (expense)
Interest income (expense)			(8,304)	455	(24,836)	1,082
Income tax benefit (expense)			(49)		(16)
Net other income (expense)			(8,353)	455	(24,852)	1,082
Income (loss) from continuing operations			51,453	43,278	130,216	124,978
Equity in earnings of consolidated subsidiaries net of income taxes			995	1,114	3,158	3,355
Net income			52,448	44,392	133,374	128,333
Income (loss) from continuing operations			51,453	43,278	130,216	124,978
Equity in earnings of consolidated subsidiaries net of income taxes			995	1,114	3,158	3,355
Net income			52,448	44,392	133,374	128,333
Net income attributable to MPT common stockholders			52,448	44,392	133,374	128,333
Non-Guarantor Subsidiaries [Member]
Revenues
Rent billed			6,424	5,650	19,431	16,328
Straight-line rent			1,432	601	2,767	1,458
Income from direct financing leases			5,921	5,751	17,691	16,744
Interest and fee income			7,338	7,317	22,631	21,872
Total revenues			21,115	19,319	62,520	56,402
Expenses
Real estate depreciation and amortization			540	702	1,929	2,107
Impairment charges					30,837
Property-related			9,171	8,291	27,474	24,137
General and administrative			2,921	(582)	3,180	(124)
Acquisition expenses			2,488		2,487
Total operating expenses			15,120	8,411	65,907	26,120
Operating income (expense)			5,995	10,908	(3,387)	30,282
Other income (expense)
Other income (expense)				(2)		(207)
Earnings from equity and other interests			1,153	843	2,059	2,511
Interest income (expense)			(7,719)	(7,267)	(22,349)	(21,892)
Income tax benefit (expense)			(200)	(94)	(216)	(261)
Net other income (expense)			(6,766)	(6,520)	(20,506)	(19,849)
Income (loss) from continuing operations			(771)	4,388	(23,893)	10,433
Income (loss) from discontinued operations				311	(2)	3,330
Net income			(771)	4,699	(23,895)	13,763
Income (loss) from continuing operations			(771)	4,388	(23,893)	10,433
Income (loss) from discontinued operations				311	(2)	3,330
Net income			(771)	4,699	(23,895)	13,763
Net income attributable to MPT common stockholders			$ (771)	$ 4,699	$ (23,895)	$ 13,763

Condensed Consolidating Financial Information - Condensed Consolidated Statements of Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Comprehensive Income (Loss) [Line Items]
Net income	$ 28,663	$ 25,703	$ 35,767	$ 79,317
Other comprehensive income (loss):
Unrealized gain on interest rate swap	1,136	182	2,342	2,788
Foreign currency translation gain (loss)	(1,319)		(1,273)
Total comprehensive income	28,480	25,885	36,836	82,105
Comprehensive income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Comprehensive income attributable to MPT common stockholders	28,354	25,830	36,644	81,940
Unrealized gain on interest rate swap	1,136	182	2,342	2,788
Total comprehensive income	28,480	25,885	36,836	82,105
Comprehensive income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Comprehensive income attributable to MPT common stockholders	28,354	25,830	36,644	81,940
Eliminations [Member]
Comprehensive Income (Loss) [Line Items]
Net income	(80,340)	(74,794)	(145,246)	(221,413)
Other comprehensive income (loss):
Unrealized gain on interest rate swap	(1,136)	(182)	(2,342)	(2,788)
Foreign currency translation gain (loss)	1,319		1,273
Total comprehensive income	(80,157)	(74,976)	(146,315)	(224,201)
Comprehensive income attributable to non-controlling interests	126	55	192	165
Comprehensive income attributable to MPT common stockholders	(80,031)	(74,921)	(146,123)	(224,036)
Unrealized gain on interest rate swap	(1,136)	(182)	(2,342)	(2,788)
Total comprehensive income	(80,157)	(74,976)	(146,315)	(224,201)
Comprehensive income attributable to non-controlling interests	126	55	192	165
Comprehensive income attributable to MPT common stockholders	(80,031)	(74,921)	(146,123)	(224,036)
Parent [Member]
Comprehensive Income (Loss) [Line Items]
Net income	28,663	25,703	35,767	79,317
Other comprehensive income (loss):
Unrealized gain on interest rate swap	1,136	182	2,342	2,788
Foreign currency translation gain (loss)	(1,319)		(1,273)
Total comprehensive income	28,480	25,885	36,836	82,105
Comprehensive income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Comprehensive income attributable to MPT common stockholders	28,354	25,830	36,644	81,940
Unrealized gain on interest rate swap	1,136	182	2,342	2,788
Total comprehensive income	28,480	25,885	36,836	82,105
Comprehensive income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Comprehensive income attributable to MPT common stockholders	28,354	25,830	36,644	81,940
Subsidiary Issuers [Member]
Comprehensive Income (Loss) [Line Items]
Net income	28,663	25,703	35,767	79,317
Other comprehensive income (loss):
Unrealized gain on interest rate swap	1,136	182	2,342	2,788
Foreign currency translation gain (loss)	(1,319)		(1,273)
Total comprehensive income	28,480	25,885	36,836	82,105
Comprehensive income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Comprehensive income attributable to MPT common stockholders	28,354	25,830	36,644	81,940
Unrealized gain on interest rate swap	1,136	182	2,342	2,788
Total comprehensive income	28,480	25,885	36,836	82,105
Comprehensive income attributable to non-controlling interests	(126)	(55)	(192)	(165)
Comprehensive income attributable to MPT common stockholders	28,354	25,830	36,644	81,940
Subsidiary Guarantors [Member]
Comprehensive Income (Loss) [Line Items]
Net income	52,448	44,392	133,374	128,333
Other comprehensive income (loss):
Total comprehensive income	52,448	44,392	133,374	128,333
Comprehensive income attributable to MPT common stockholders	52,448	44,392	133,374	128,333
Total comprehensive income	52,448	44,392	133,374	128,333
Comprehensive income attributable to MPT common stockholders	52,448	44,392	133,374	128,333
Non-Guarantor Subsidiaries [Member]
Comprehensive Income (Loss) [Line Items]
Net income	(771)	4,699	(23,895)	13,763
Other comprehensive income (loss):
Total comprehensive income	(771)	4,699	(23,895)	13,763
Comprehensive income attributable to MPT common stockholders	(771)	4,699	(23,895)	13,763
Total comprehensive income	(771)	4,699	(23,895)	13,763
Comprehensive income attributable to MPT common stockholders	$ (771)	$ 4,699	$ (23,895)	$ 13,763

Condensed Consolidating Financial Information - Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities
Net cash provided by (used in) operating activities	$ 95,744	$ 101,564
Investing activities
Cash paid for acquisitions and other related investments	(182,982)	(371,500)
Principal received on loans receivable	8,381	4,694
Net proceeds from sale of real estate	34,649	18,409
Investments in loans receivable	(9,102)	(1,445)
Construction in progress and other	(97,002)	(63,422)
Net cash used for investing activities	(246,056)	(413,264)
Financing activities
Revolving credit facilities, net	(105,000)	(80,000)
Additions to term debt	425,000	153,000
Payments of term debt	(100,197)	(11,185)
Distributions paid	(108,026)	(87,928)
Proceeds from sale of common shares/units, net of offering costs	128,270	313,319
Lease deposits and other obligations to tenants	10,879	3,589
Debt issuance costs paid and other financing activities	(11,757)	(4,282)
Net cash provided by financing activities	239,169	286,513
Increase (decrease) in cash and cash equivalents for period	88,857	(25,187)
Effects of exchange rate changes on cash	(2,024)
Cash and cash equivalents at beginning of period	45,979	37,311
Cash and cash equivalents at end of period	132,812	12,124
Eliminations [Member]
Financing activities
Distributions paid	107,842	87,727
Proceeds from sale of common shares/units, net of offering costs	(128,270)	(313,319)
Net payments relating to intercompany financing	20,428	225,592
Parent [Member]
Operating activities
Net cash provided by (used in) operating activities	(98)	91
Financing activities
Distributions paid	(107,842)	(87,727)
Proceeds from sale of common shares/units, net of offering costs	128,270	313,319
Net payments relating to intercompany financing	(20,330)	(225,683)
Net cash provided by financing activities	98	(91)
Subsidiary Issuers [Member]
Operating activities
Net cash provided by (used in) operating activities	(76,425)	(38,891)
Investing activities
Construction in progress and other	(1,030)	(765)
Net cash used for investing activities	(1,030)	(765)
Financing activities
Revolving credit facilities, net	(105,000)	(80,000)
Additions to term debt	425,000
Payments of term debt	(100,176)	(11,000)
Distributions paid	(108,026)	(87,928)
Proceeds from sale of common shares/units, net of offering costs	128,270	313,319
Lease deposits and other obligations to tenants	(360)
Net payments relating to intercompany financing	(61,206)	(267,545)
Debt issuance costs paid and other financing activities	(11,757)	(4,282)
Net cash provided by financing activities	166,745	15,564
Increase (decrease) in cash and cash equivalents for period	89,290
Cash and cash equivalents at beginning of period	18,815	35,483
Cash and cash equivalents at end of period	108,105	11,391
Subsidiary Guarantors [Member]
Operating activities
Net cash provided by (used in) operating activities	221,310	171,742
Investing activities
Cash paid for acquisitions and other related investments	(182,982)	(356,250)
Construction in progress and other	(95,489)	(63,690)
Net cash used for investing activities	(278,471)	(419,940)
Financing activities
Lease deposits and other obligations to tenants	9,431	1,699
Net payments relating to intercompany financing	46,445	244,934
Net cash provided by financing activities	55,877	246,633
Increase (decrease) in cash and cash equivalents for period	(1,284)
Effects of exchange rate changes on cash	(2,024)
Cash and cash equivalents at beginning of period	27,094	1,565
Cash and cash equivalents at end of period	23,786
Non-Guarantor Subsidiaries [Member]
Operating activities
Net cash provided by (used in) operating activities	(49,043)	(31,378)
Investing activities
Cash paid for acquisitions and other related investments		(15,250)
Principal received on loans receivable	8,381	4,694
Net proceeds from sale of real estate	34,649	18,409
Investments in loans receivable	(9,102)	(1,445)
Construction in progress and other	(483)	1,033
Net cash used for investing activities	33,445	(7,441)
Financing activities
Payments of term debt	(21)	(185)
Lease deposits and other obligations to tenants	1,808	1,890
Net payments relating to intercompany financing	14,662	22,702
Net cash provided by financing activities	16,449	24,407
Increase (decrease) in cash and cash equivalents for period	851
Cash and cash equivalents at beginning of period	70	263
Cash and cash equivalents at end of period	$ 921	$ 733